phencyclidine has been researched along with Disease Models, Animal in 471 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (10.40) | 18.7374 |
1990's | 53 (11.25) | 18.2507 |
2000's | 137 (29.09) | 29.6817 |
2010's | 187 (39.70) | 24.3611 |
2020's | 45 (9.55) | 2.80 |
Authors | Studies |
---|---|
Cao, H; Hu, D; Li, B; Liu, J; Liu, Q; Mu, M; Sun, Q; Tao, X; Wang, J; Xu, K; Zhang, J | 1 |
Choi, WS; Kim, HJ; Kim, JH; Kwon, OS; Lee, JY; Park, TI; Song, JY | 1 |
Cao, H; Chen, H; Ge, D; Li, B; Li, C; Li, Z; Mu, M; Sun, Q; Tao, H; Tao, X; Tian, K; Wang, W; Zhang, S; Zou, Y | 1 |
Ichinose, T; Maki, T; Nishikawa, M; Sadakane, K | 1 |
Cao, H; Hu, D; Li, B; Mu, M; Tao, X; Wang, W; Zou, Y | 1 |
Cao, H; Chen, H; Li, B; Liu, Y; Mu, M; Tao, X; Zhao, Y; Zou, Y | 1 |
Baba, R; Kanazawa, T; Morimoto, H; Morita, K; Song, Y; Wang, D; Yoshida, Y | 1 |
Jeon, HY; Kim, N; Kim, S; Park, BW; Park, SJ; Piao, Z; Rahman, MM; Seo, SB; Yoo, JK | 1 |
Baack, ML; Dominguez, EC; Guardado, S; Heires, AJ; Larsen, TD; Nordgren, TM; Pavlik, J; Romberger, DJ; Sisson, JH | 1 |
Chang, K; Chen, D; Guan, L; Hu, C; Huang, N; Li, D; Li, J; Lin, J; Liu, X; Liu, Z; Tsui, SK; Xiong, Q; Yang, PC; Zhong, N | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Bae, H; Lee, J; Lee, YS; Min, D; Park, SY | 1 |
Abdel Gaber, NAT; Abdel-Fatah, MM; Abdel-Hafeez, EH; Ahmed, RF; Belal, US; Gabr, NS; Mohamed, RM | 1 |
Barger, M; Coyle, J; Dozier, AK; Fedan, JS; Friend, SA; Hubbs, AF; Jackson, MC; Kashon, ML; Leonard, SS; McKinney, W; Park, JH; Roberts, JR; Schwegler-Berry, D; Snawder, JE; Thompson, JA | 1 |
Bhat, SM; Charavaryamath, C; Massey, N; Rumbeiha, WK; Santana Maldonado, C; Shrestha, D | 1 |
Barry, AE; Duryee, MJ; England, BR; Eudy, JD; Gaurav, R; Guda, C; Mikuls, TR; Nelson, AJ; Niu, M; Poole, JA; Romberger, DJ; Thiele, GM; Wyatt, TA | 1 |
Campen, MJ; Cerrato, JM; Herbert, GW; Li, QZ; Lucas, SN; Sanchez, BN; Spilde, M; Velasco, CA; Wilson, A; Zychowski, KE | 1 |
Bhat, SM; Charavaryamath, C; Charli, A; Kanthasamy, AG; Karriker, LA; Kondru, N; Massey, N; Shrestha, D | 1 |
Kirychuk, S; Pandher, U; Schneberger, D; Thompson, B | 1 |
Baack, M; Bravo, C; Burr, A; DiPatrizio, NV; Heires, AJ; Larsen, T; Nordgren, TM; Pavlik, J; Perez, PA; Romberger, DJ; Ulu, A | 1 |
Carrington, JM; Poole, JA | 1 |
Demers, AM; Diacon, AH; Donald, PR; Lange, C; Nardell, E; von Groote-Bidlingmaier, F | 1 |
Che, S; Liu, K; Liu, Z; Wang, H; Wang, K; Yang, H; Zhang, N; Zhou, C | 1 |
Cook, DN; Izumi, G; Jetten, AM; Kang, HS; Karcz, TP; Makarov, SS; Medvedev, A; Nakano, H; Nakano, K; Thomas, SY; Whitehead, GS | 1 |
Ilderbayev, OZ; Ilderbayeva, GO; Olzhayeva, RR; Prozor, II; Tapbergenov, SO; Usenova, OA; Zhetpisbaev, BA; Zhetpisbaeva, HS | 1 |
Bellmann, B; Bernstein, DM; Ernst, H; Kunzendorf, P; Phillips, JI; Rogers, R; Sepulveda, R | 1 |
Brandsma, CA; Draijer, C; Heederik, D; Hylkema, MN; Luinge, M; Melgert, BN; Robbe, P; Spierenburg, EA; Telenga, E; Timens, W; van den Berge, M; van Oosterhout, AJ; Wouters, IM | 1 |
Mimura, T | 1 |
Arashidani, K; He, M; Ichinose, T; Nishikawa, M; Ren, Y; Shibamoto, T; Sun, G; Takano, H; Yoshida, S; Yoshida, Y | 1 |
Kurai, J; Sano, H; Shimizu, E; Tomita, K; Watanabe, M; Yamasaki, A; Yamasaki, HS | 1 |
Friemel, TD; Heires, AJ; Nordgren, TM; Poole, JA; Romberger, DJ; Wyatt, TA | 1 |
Gerald, CL; McClendon, CJ; Waterman, JT | 1 |
Bauer, CD; Heires, AJ; Nordgren, TM; Poole, JA; Romberger, DJ; West, WW; Wyatt, TA | 1 |
Boten, JA; DeVasure, JM; Gordon, JR; Heires, AJ; Romberger, DJ; Schneberger, D; Wyatt, TA | 1 |
Choi, EJ; Choi, JP; Gho, YS; Heo, YJ; Jee, YK; Kim, YK; Kim, YS; Lee, WH; Oh, YM | 1 |
Hua, H; Jin, K; Li, B; Li, T; Li, Z; Liu, S; Ma, L; Ruan, Y; Tuo, X; Zhou, Z | 1 |
Chen, J; Chen, R; Feng, L; Jiang, Z; Li, X; Lou, J; Xia, H; Xiao, Y; Yin, X; Yu, M; Zhang, X; Zhu, L | 1 |
Clarey, D; Duryee, MJ; Dusad, A; Klassen, LW; Mikuls, TR; Poole, JA; Romberger, DJ; Staab, E; Thiele, GM; Wang, D; Wells, AD; Wyatt, TA | 1 |
Anderson, RL; Gilbert, JA; Gozdz, J; Holbreich, M; Hrusch, CL; Igartua, C; Ledford, JG; Maier, RM; Marques Dos Santos, M; Martinez, FD; Metwali, N; Murray, SE; Neilson, JW; Ober, C; Pivniouk, V; Sperling, AI; Stein, MM; Thorne, PS; Vercelli, D; von Mutius, E | 1 |
Hantan, D; Kurai, J; Sano, H; Shimizu, E; Tohda, Y; Watanabe, M | 1 |
Duryee, MJ; Dusad, A; Heires, AJ; Klassen, LW; Mikuls, TR; Poole, JA; Romberger, DJ; Staab, E; Thiele, GM; Wang, D; Wells, A; West, WW; Wyatt, TA | 1 |
Cieslak, M; Halatek, T; Kaminska, I; Stanislawska, M; Swiercz, R; Wasowicz, W | 1 |
Brass, DM; Garantziotis, S; Hollingsworth, JW; Marraccini, P; Maruoka, S; Schwartz, DA | 1 |
Elliott, MK; Oldenburg, PJ; Poole, JA; Romberger, DJ; Sisson, JH; Von Essen, SG; West, WW; Wyatt, TA | 1 |
Gordon, JR; Li, F; Nayyar, A; Town, J; Zhang, X; Zhao, X | 1 |
Cleave, J; Gordon, JR; Town, J; Willson, PJ | 1 |
Bufe, A; Gehlhar, K; Holst, O; Kauth, M; Peters, M; Scherner, O; Steffen, I; von Mutius, E; Wentker, P | 1 |
Inoue, K; Morita, T; Mukaiyama, T; Naota, M; Okajima, M; Shimada, A; Takano, H; Yoshida, A | 1 |
Clark, JR; Gerard, C; Gerard, NP; Köhl, J; König, P; Laumonnier, Y; Pandey, MK; Schmudde, I; Wills-Karp, M; Zhang, X | 1 |
Bauer, A; Gleason, AM; Golden, G; Kielian, T; Oldenburg, P; Poole, JA; Romberger, DJ; Sisson, JH; West, WW; Wyatt, TA | 1 |
Lavoie, JP; Lavoie-Lamoureux, A; Leclere, M | 1 |
Chen, J; Chen, JY; Li, SM; Lin, CL; Liu, WW; Liu, YM; Tang, LJ; Yu, W; Zhang, C; Zhong, XY | 1 |
Beasley, VR; Ferguson, DC; Mensching, DA; Scott, JW; Slater, M | 1 |
Cha, HE; Choe, SH; Jung, JH; Kang, IG; Kim, ST | 1 |
Bailey, KL; Boten, J; DeVasure, J; McCaskill, ML; Poole, JA; Romberger, DJ; Sisson, JH; Wyatt, TA | 1 |
Bauer, C; Gleason, AM; Oldenburg, PJ; Poole, JA; Romberger, DJ; Sisson, JH; West, WW; Wyatt, TA | 1 |
Bufe, A; Peters, M; Stiehm, M | 1 |
Bauer, C; Gleason, AM; Golden, GA; McCaskill, M; Poole, JA; Reiff, D; Romberger, DJ; Wyatt, TA | 1 |
Ichinose, T; Sadakane, K; Sagai, M; Shibamoto, T; Takano, H; Yanagisawa, R; Yoshikawa, T | 1 |
George, CL; O'Neill, ME; Schwartz, DA; Snyder, JM; Thorne, PS; White, ML | 1 |
Dormans, JA; Steerenberg, PA; van Dalen, WJ; van Loveren, H; Withagen, CE | 1 |
Coyle, AJ; Ellis, R; Fattouh, R; Gajewska, BU; Gutierrez-Ramos, JC; Inman, MD; Johnson, JR; Jordana, M; Swirski, FK; Wiley, RE | 1 |
Ehrmann, D; Hooker, JL; Kukoly, C; Nyce, J; Salleng, K; Sandrasagra, A; Shibata, Y; Van Scott, MR; Westergaard, G | 1 |
Dong, Q; He, P; Wu, D | 1 |
Li, H; Liu, Z; Meng, A; Wang, P; Wu, Y; Xu, D; Xu, Y; Zhu, R | 1 |
Bolgos, GL; Kim, J; McKinley, L; Remick, DG; Siddiqui, J | 3 |
Cates, EC; Coyle, AJ; Fattouh, R; Goncharova, S; Gutierrez-Ramos, JC; Inman, MD; Jordana, M; Wattie, J | 1 |
Cassee, FR; Dormans, JA; Heisterkamp, SH; Steerenberg, PA; van Dalen, WJ; van Loveren, H; Withagen, CE | 1 |
Batra, VK; Borron, P; Mustafa, SJ; Nadeem, A; Obiefuna, PC; Wilson, CN | 1 |
Kaiserling, E; Kaiserling, K; Müller, KM | 1 |
Knashina, GM; Kulkybaev, GA; Namazbaeva, ZI; Rakhishev, EK | 1 |
Amanzhol, IA; Musin, EM; Otarov, EZh; Tatkeev, TA; Zharylkasyn, ZhZh | 1 |
Cohn, L; Homer, RJ; Mariani, TJ; Severgnini, M; Simeone-Penney, MC; Simon, AR; Tu, P | 1 |
Alenius, H; Haapakoski, R; Husgafvel-Pursiainen, K; Lehto, M; Leino, M; Määttä, J; Savolainen, K; Tillander, S; Wolff, H | 1 |
Gao, Q; Hua, HR; Jin, KW; Liang, R; Ruan, YH; Song, JL | 1 |
Choi, JE; Davis-Gorman, G; Diven, C; Finnerty, K; Lau, A; Linak, WP; McDonagh, PF; Seaver, N; Witten, M | 1 |
Ehnhage, A; Grudemo, H; Juto, JE; Kölbeck, KG; Stjärne, P | 1 |
Hiyoshi, K; Ichinose, T; Kawazato, H; Mori, I; Nishikawa, M; Sadakane, K; Shibamoto, T; Takano, H; Yanagisawa, R; Yasuda, A; Yoshida, S | 1 |
Anhenn, O; Fey, K; Hotzel, H; Mentrup, B; Sachse, K; Theegarten, D | 1 |
Andersen, ME; Clewell, HJ; Dorman, DC; Nong, A; Teeguarden, JG | 1 |
Barger, M; Battelli, LA; Ghanem, MM; Hubbs, AF; Kashon, ML; Ma, JY; Miles, PR; Simoskevitz, RL | 1 |
Sunaga, Y | 1 |
Amenta, PS; Barbieri, EJ; Blumenstein, R; DiPalma, JR; Freedman, AP; McMichael, RF | 1 |
Fink, JN | 1 |
Alarie, YC; Ellakkani, MA; Karol, MH; Mazumdar, S; Weyel, DA | 1 |
Donham, KJ; Leininger, JR | 1 |
Arden-Jones, MP; Gray, RL; Hahn, FF; Marx, JJ; Motszko, CS; Treuhaft, MW | 1 |
Ballantyne, B | 1 |
Anderson, R; Bernstein, DM; Hadley, J; Hesterberg, TW; Kamstrup, O; Mast, R; Musselman, R | 1 |
Harris, KE; Hogan, MB; Patterson, R | 1 |
Afshari, A; Barger, MW; Castranova, V; Frazer, DG; Jones, T; Jones, WG; Kullman, GJ; Petsonk, EL | 1 |
Gilmour, MI; Selgrade, MJ | 1 |
Buck, MG; Goswami, S; Maayani, S; Marom, Z; Rienzi, N; Schachter, EN; Zuskin, E | 1 |
Cheng, KC; Choe, IS; Krug, MS; Lee, KM; Suzuki, M; Watanabe, T; Yoo, TJ | 1 |
Davis, GS; Hemenway, DR; Leslie, KO | 1 |
Okudaira, H; Okumura, Y; Suko, M; Yasue, M; Yokota, T | 1 |
Guhl, W | 1 |
Belokon', AM; Kazakov, VN; Korzh, EV; Shcherbakov, KS; Siniachenko, OV; Vladzimirskiĭ, AV | 1 |
Kips, JC; Pauwels, RA; Schou, C; Tournoy, KG | 1 |
Abo-el-Nazar, SY; Allam, SR; Rezk, HA; Sadaka, HA; Shola, AY | 1 |
Abebe, Y | 1 |
George, CL; Jin, H; Kline, JN; O'Neill, ME; O'Shaughnessy, P; Phipps, JC; Schwartz, DA; Thorne, PS; Wohlford-Lenane, CL | 1 |
Honnons, S; Porcher, JM | 1 |
Dobroliubova, LP; Kashanskiĭ, SV; Kogan, FM; Shcherbakov, SV; Troitskaia, NA; Vanchugova, NN; Zykova, VA | 1 |
Chan, B; Desjardin, N; Jardieu, P; Shields, RL; Tumas, DB; Vennari, J; Werther, W; Wrin, T | 1 |
Bezrukavnikova, LM; Kuz'mina, LP; Mironova, GE | 1 |
Bolgos, GL; Kim, J; Merry, AC; Nemzek, JA; Remick, DG; Siddiqui, J | 1 |
Chandra, H; Gupta, GS; Mehrotra, NK | 1 |
Kaw, JL; Singh, J; Zaidi, SH | 1 |
Eidson, G; Hatcher, JD; Walker, RF | 1 |
Dogra, RK; Sahu, AP; Shanker, R; Zaidi, SH | 1 |
Breining, H; Rosmanith, J | 1 |
Hand, JM; Osborn, RR; Underwood, DC | 1 |
Ociepiński, M; Szaflarska-Stojko, E; Zyłka-Włoszczyk, M | 3 |
Tátrai, E; Ungváry, G | 1 |
Domagała, B; Olczyk, D; Szaflarska-Stojko, E | 2 |
Duma, ZV; Erokhin, VV; Gedymin, LE; Khomenko, AG | 1 |
Barnes, PJ; Chung, KF; Daniel, R; Hayes, JP; Taylor, AJ; Tee, RD | 1 |
Olczyk, D; Szaflarska-Stojko, E; Szymczykiewicz, K | 2 |
Fedorova, NE; Gvozdeva, LL; Ivanova, LG; Kozlova, AV; Lutsenko, LA | 1 |
Olczyk, D; Szaflarska-Stojko, E; Szymczykiewicz, K; Zyłka-Włoszczyk, M | 1 |
Brown, DM; Brown, GM; Cullen, RT; Donaldson, K; Love, RG; Slight, J; Soutar, CA | 1 |
Ino, Y; Iwaki, M; Miyamoto, T; Okudaira, H; Suko, M; Yamakawa, H | 1 |
Gardner, DE | 1 |
Salvaggio, JE | 1 |
Reynolds, HY | 1 |
Baumal, R; Broder, I; Stepner, N | 1 |
Pichkhadze, GM | 1 |
Druzhinin, VN; Elovskaia, LT; Grigorian, EA; Iaglov, VV; Kapitanov, IuT | 1 |
Ebbesen, P | 1 |
Côté, MG; Coulombe, PA; Filion, PR | 1 |
Weller, W | 1 |
Fitschen, W; Webster, I | 1 |
Wewer, B | 1 |
Stepanov, SA | 3 |
Ito, F | 1 |
Dale, K | 1 |
Horai, Z; Matsumura, K; Shimizu, K; Ueda, Y; Yoneda, H | 1 |
Kilburn, KH | 1 |
Kilburn, KH; Lynn, WS; McKenzie, WN; Tres, LL | 1 |
Kaw, JL; Zaidi, SH | 1 |
Dzhangozina, DM; Kabaev, ShK; Nurumov, AT; Zhakenova, RK | 1 |
Botham, SK; Holt, PF | 1 |
Chaĭka, PA; Minko, VA | 1 |
deTreville, RT; Gross, P | 1 |
Chandra, SV; Dogra, RK; Shanker, R; Zaidi, SH | 1 |
Huković, S; Jordanov, T; Miksić, J | 1 |
Rasche, B; Ulmer, WT; Würfel, P | 1 |
Abreu-Villaça, Y; Couto, LA; Dutra-Tavares, AC; Filgueiras, CC; Maia, JG; Manhães, AC; Ribeiro-Carvalho, A; Semeão, KA | 1 |
Amani, M; Golitabari, N; Mohammadian, F; Salari, AA | 1 |
Dwyer, DM; Griesius, S; Hall, J; Humby, T; Mellor, JR; Pass, R; Robinson, ESJ; Thomas, KL; Waldron, S; Wilkinson, LS | 1 |
Dalton, CF; Fachim, HA; Harte, MK; Loureiro, CM; Reynolds, GP | 1 |
Gogos, A; Kusljic, S; van den Buuse, M | 1 |
Chang, MH; Chiou, LC; Cook, J; Knutson, DE; Kubota, H; Lee, HJ; Lee, MT; Mihovilovic, M; Mouri, A; Nabeshima, T; Sieghart, W; Wu, CY | 1 |
Bécamel, C; Delagrange, M; Doyle, JP; Heintz, N; Iyer, K; Paul, MA; Selimi, F; Sigoillot, SM; Urrieta-Chávez, B; Usardi, A; Veleanu, M | 1 |
Arai, T; Matsumoto, M; Yamazaki, M; Yarimizu, J | 1 |
Deng, W; Guo, W; Hu, X; Li, T; Ma, X; Ni, P; Qi, X; Wang, Q; Wei, L; Yu, X; Zhao, L | 1 |
Burgess, M; Grayson, B; Harte, MK; Landreth, K; Lorusso, JM; Neill, JC; Watson, L | 1 |
Abreu-Villaça, Y; Dutra-Tavares, AC; Filgueiras, CC; Manhães, AC; Mello, FF; Ribeiro-Carvalho, A; Semeão, KA; Silva, JO; Souza, TP | 1 |
Abreu-Villaça, Y; Dutra-Tavares, AC; Filgueiras, CC; Manhães, AC; Ribeiro-Carvalho, A; Rodríguez-Vega, A; Semeão, KA; Souza, TP | 1 |
Brown, SJ; du Bois, TM; Huang, XF; Katsifis, A; Lum, JS; Mattner, F; Newell, KA | 1 |
Fan, ZL; Hu, KH; Li, X; Sui, JF; Wu, B; Wu, GY; Yao, J; Zhou, ZH | 1 |
Giuffrida, A; Martinez, AA; Seillier, A | 1 |
Burgess, M; Grayson, B; Idris, NF; Mitsadali, I; Neill, J; Watson, L | 1 |
Armstrong, JD; Brett, RR; Mitchell, EJ; Pratt, JA; Sillito, RR | 1 |
Brown, AM; Dawe-Lane, E; Evans, C; Fowler, M; King, MV; Newton-Mann, E; Shortall, SE | 1 |
Bikovski, L; Goldshmit, Y; Offen, D; Perets, N; Ruban, A; Sofer, T; Tsivion-Visbord, H | 1 |
Arioka, Y; Goto, S; Kitagaki, S; Kushima, I; Mamiya, T; Mouri, A; Noda, Y; Ozaki, N; Uchida, M; Yamada, S; Yoshimi, A | 1 |
Babin, D; Castagné, V; Hamieh, AM; Hernier, AM; Sablé, E | 1 |
Hata, T; Hiraga, T; Koizumi, H; Mouri, A; Nabeshima, T; Oharomari, LK; Okamoto, M; Shima, T; Soya, H; Yook, JS | 1 |
Bastlund, JF; Eneberg, E; Gerdjikov, TV; Hayes, J; Kehler, J; Langgard, M; Laursen, B; Rasmussen, LK | 1 |
Kim, HR; Martina, M; Meltzer, HY; Rajagopal, L | 1 |
Goto, S; Ito, T; Kitagaki, S; Mamiya, T; Mouri, A; Noda, Y; Ozaki, N; Soeda, K; Uchida, M; Yoshimi, A | 1 |
Dawson, N; Diógenes, MJ; Ferreira, CB; Fonseca-Gomes, J; Freitas, CF; Mouro, FM; Sebastião, AM; Simões do Couto, F; Tanqueiro, SR | 1 |
Dai, Z; Liu, J; Sui, Y; Wang, X | 1 |
Coen, KM; Fletcher, PJ; Lê, AD; Li, Z | 1 |
Forsberg, MM; Gröhn, O; Ihalainen, J; Lehtonen, M; Leikas, JV; Paasonen, J; Salo, RA; Savolainen, K | 1 |
Guest, PC; Ma, D | 1 |
Bhat, L; Cantillon, M; Huang, M; Kwon, S; Meltzer, HY; Michael, E; Rajagopal, L | 1 |
Harte, MK; McLean, SL; Neill, JC; Young, AM | 1 |
Dalby, NO; Hovelsø, N; Kjaerby, C; Sotty, F | 1 |
Arias, HR; Manetti, D; Romanelli, MN; Wadenberg, MG | 1 |
Giuffrida, A; Seillier, A | 3 |
Doron, R; Golani, I; Kremer, I; Shamir, A; Tadmor, H | 1 |
Bauer-Erickson, J; Berquist, MD; Fantegrossi, WE; Gannon, BM; Hyatt, WS; Norwood, AP | 1 |
Nishikawa, T; Shiwaku, H; Umino, A; Umino, M | 1 |
Hales, CA; Houghton, CJ; Robinson, ESJ | 1 |
Jang, CG; Jeong, JH; Kim, HC; Lee, YJ; Nabeshima, T; Nah, SY; Park, SJ; Shin, EJ; Tran, HQ; Tran, TV | 1 |
Amitai, N; Powell, SB; Young, JW | 1 |
Christensen, KV; Christoffersen, CT; Clausen, D; Didriksen, M; Egebjerg, J; Fejgin, K; Kallunki, P; Larsen, PH; Lauridsen, JB; Mørk, A; Nielsen, J; Nielsen, V; Sotty, F; Werge, TM; Yavich, L | 1 |
Feng, J; Jia, M; Liu, J; Wen, X; Zhang, G; Zhang, W | 1 |
Brosda, J; Tarland, E | 1 |
Liu, Q; Liu, T; Ma, Y; Shan, L; Xu, F; Zhang, M; Zhang, Y; Zhang, Z; Zhao, X | 1 |
Fried, J; Paine, TA; Riordan, AJ; Schaler, AW; Thornton, JE | 1 |
Adham, N; Gyertyán, I; Ichinose, F; Kehr, J; Kiss, B; Yoshitake, S; Yoshitake, T | 1 |
Malikowska-Racia, N; Podkowa, A; Sałat, K | 1 |
Majeed, ABA; Mani, V; Mohamed, Z; Pandy, V; Rouhollahi, E; Wong, WF; Zain, MA | 1 |
Piyabhan, P; Wetchateng, T | 2 |
Jang, CG; Jeong, JH; Kim, DJ; Kim, HC; Lee, YJ; Nabeshima, T; Park, SJ; Sharma, N; Shin, EJ; Tran, HQ; Tran, TV | 1 |
Chen, T; He, L; Jia, XF; Li, YX; Ye, ZH | 1 |
Bernardo, A; Daya, R; Dyck, B; Ho, J; Mishra, RK; Thomson, S; Tian, Y | 1 |
Chen, W; Guo, S; He, Y; Hu, T; Jiang, X; Shen, J; Tian, G; Wang, Y; Wang, Z; Wu, C; Xie, Y; Xu, M; Yang, F; Zhao, Q; Zhu, F | 1 |
Al-Ali, AM; Young, AMJ | 1 |
Kimura, H; Kunugi, A; Suzuki, A; Suzuki, M; Suzuki, N; Tanaka, M | 1 |
Aida, T; Hida, H; Hiraoka, Y; Kitagaki, S; Mori, K; Noda, Y; Ozaki, N; Tanaka, K; Uchida, M; Yamada, K; Yoshimi, A | 1 |
Aznar, S; Klein, AB; Knudsen, GM; Mikkelsen, JD; Ratner, C; Santini, MA | 1 |
Hida, H; Mouri, A; Noda, Y | 1 |
Bolger, FB; Finnerty, NJ; Lowry, JP; Pålsson, E | 1 |
Bjelke, B; Broberg, BV; Glenthøj, BY; Madsen, KH; Olsen, CK; Paulson, OB; Plath, N; Søgaard, LV | 1 |
Khattak, HZ; Lee, JL; Richardson, L; Vreugdenhil, M; Ward, KC | 1 |
Jodo, E | 1 |
Artigas, F; Celada, P; Kargieman, L; Lladó-Pelfort, L; Riga, MS; Santana, N; Troyano-Rodriguez, E | 1 |
Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
Avenet, P; Bergis, O; Boulay, D; Griebel, G; Ho-Van, S | 1 |
Piyabhan, P; Sireeratawong, S; Wetchateng, T | 1 |
Bahn, S; Chan, MK; Ernst, A; Guest, PC; Holmes, E; Peters, F; Tsang, TM; Wesseling, H | 1 |
Kaalund, SS; Karlsen, AS; Møller, M; Pakkenberg, B; Plath, N | 1 |
Antonelli, T; Beggiato, S; Ferraro, L; Parolaro, D; Prini, P; Rubino, T; Steardo, L; Zamberletti, E | 1 |
Alexander, SP; Fone, KC; Gaskin, PL | 1 |
Corches, A; Korzus, E; Lovelace, JW; Mackie, K; Vieira, PA | 1 |
Beck, HC; Hansen, HH; Jensen, ON; Mikkelsen, JD; Palmowski, P; Rogowska-Wrzesinska, A; Williamson, J | 1 |
Adamson, L; Grayson, B; Harte, M; Leger, M; Marsh, S; Neill, JC; Piercy, C | 1 |
Aerts, N; Fellini, L; Steckler, T; Talpos, JC | 1 |
Berckel, BN; Donck, LV; Klein, PJ; Kooijman, EJ; Leysen, JE; Metaxas, A; Renjaän, VA; Willems, R; Windhorst, AD | 1 |
Parachikova, AI; Pedersen, CS; Plath, N; Sørensen, DB | 1 |
Jenkins, TA; McKibben, CE; Reynolds, GP | 1 |
Biguet, NF; Ingallinesi, M; Le Bouil, L; Mallet, J; Mannoury la Cour, C; Meloni, R; Millan, MJ; Ravassard, P; Thi, AD | 1 |
Fellini, L; Gibbs, S; Kumar, G; Steckler, T; Talpos, J | 1 |
Horiguchi, M; Meltzer, HY; Miyauchi, M; Oyamada, Y; Rajagopal, L | 1 |
Diano, S; Elsworth, JD; Groman, SM; Jentsch, JD; Kim, JD; Leranth, C; Redmond, DE; Roth, RH | 1 |
Aguilar, DD; Chen, L; Lodge, DJ | 1 |
Hansen, AK; Krych, L; Larsen, C; Nielsen, DS; Pedersen, CS; Pedersen, TB; Plath, N; Pyndt Jørgensen, B; Redrobe, JP; Sørensen, DB | 1 |
Barnes, SA; Buonincontri, G; Caprioli, D; Dalley, JW; Fletcher, PC; Harte, MK; Jupp, B; Mar, AC; Neill, JC; Robbins, TW; Sawiak, SJ | 1 |
Angrisano, T; Bertolino, A; Chiariotti, L; D'Argenio, V; de Bartolomeis, A; Di Maio, A; Errico, F; Galbusera, A; Gozzi, A; Guerri, G; Iasevoli, F; Keller, S; Napolitano, F; Salvatore, F; Sforazzini, F; Squillace, M; Usiello, A; Vitucci, D | 1 |
Cui, D; Ma, YY; Mao, P; Zhao, XD | 1 |
Burdi, DF; Campbell, JE; Campbell, U; Herman, L; Hewitt, MC; Jones, PG; Koch, P; Shao, L; Wang, J; Wei, J; Zhao, S; Zhong, H | 1 |
Abe, K; Aoki, T; Chaki, S; Iijima, M; Kaku, A; Kambe, D; Karasawa, J; Kawakita, Y; Okubo, T; Okuyama, S; Sekiguchi, Y; Shibata, T; Shimazaki, T; Yamamoto, S | 1 |
Maher, P; Martínez-Bartolomé, S; McClatchy, DB; Park, SK; Powell, SB; Savas, JN; Yates, JR | 1 |
Artigas, F; Castañé, A; Santana, N | 1 |
Amano, Y; Hamaguchi, W; Hattori, K; Kikuchi, S; Masuda, N; Mihara, T; Miyamoto, S; Moriguchi, H; Narazaki, F; Seo, R; Shiina, Y | 1 |
Bahn, S; Guest, PC; Holmes, E; Rahmoune, H; Want, EJ; Wesseling, H | 1 |
Ballard, TM; Haman, M; Janhunen, SK; Kumar, G; Lerdrup, L; Plath, N; Ruby, T; Steckler, T; Svärd, H; Talpos, J; Wyler, R | 1 |
Fujita, Y; Hashimoto, K; Hashimoto, R; Ishima, T; Ohi, K; Shirai, Y; Suganuma, H; Takeda, M; Ushida, Y; Yamamori, H; Yasuda, Y | 1 |
Conn, PJ; Daniels, JS; Dickerson, JW; Ghoshal, A; Jalan-Sakrikar, N; Jones, CK; Lamsal, A; Lindsley, CW; Melancon, BJ; Morrison, RD; Niswender, CM; Noetzel, MJ; Poslusney, MS; Rook, JM; Roop, GN; Stauffer, SR; Wood, MR; Xiang, Z | 1 |
Caron, MG; Chen, M; Dulman, RS; Jin, J; Park, SM; Rodriguiz, RM; Schmerberg, CM; Wetsel, WC | 1 |
Gass, P; Inta, D; Pfeiffer, N; Vogel, AS; Vogt, MA | 1 |
Horiguchi, M; Meltzer, HY; Miyauchi, M; Neugebauer, NM; Oyamada, Y | 1 |
Li, M; Mulholland, MM; Schulz, TD; Swalve, N | 1 |
Aguilar, DD; Giuffrida, A; Lodge, DJ | 1 |
Meltzer, HY; Miyauchi, M; Neugebauer, NM; Oyamada, Y | 1 |
Burgdorf, JS; Meltzer, HY; Moskal, JR; Rajagopal, L | 1 |
Adham, N; Ferguson, P; Grayson, B; Gyertyán, I; Kiss, B; Neill, JC | 1 |
Barnes, SA; Bate, ST; Neill, JC; Young, JW | 1 |
Adham, N; Fone, KCF; Gyertyán, I; King, MV; Kiss, B; Watson, DJG | 1 |
Engel, M; Frank, E; Huang, XF; Matosin, N; Newell, KA; Snikeris, P | 1 |
Forsberg, MM; Ihalainen, J; Savolainen, K; Tanila, H | 1 |
Bantreil, X; Bojarski, AJ; Chaumont-Dubel, S; Colacino, E; Grychowska, K; Kos, T; Lamaty, F; Marin, P; Martinez, J; Partyka, A; Pawłowski, M; Popik, P; Satała, G; Subra, G; Wesołowska, A; Zajdel, P | 1 |
Doostdar, N; Neill, JC; Sahin, C | 1 |
Bahn, S; Cooper, JD; Cox, DA; Ernst, A; Gottschalk, MG; Wesseling, H | 1 |
Alexander, SP; Fone, KC; Gaskin, PL; Toledo-Rodriguez, M | 1 |
Naowaboot, J; Piyabhan, P; Wannasiri, S | 1 |
Pitsikas, N | 1 |
Gil-Ad, I; Krivoy, A; Taler, M; Tarasenko, I; Weizman, A | 1 |
Andrews, JL; Fernandez-Enright, F; Goodfellow, FJ; Huang, XF; Matosin, N; Newell, KA; Snelling, MK | 1 |
Peters, SM; Pinter, IJ; Spruijt, BM; Tuffnell, JA; van der Harst, JE | 1 |
Asif-Malik, A; Dautan, D; Gerdjikov, TV; Young, AMJ | 1 |
Chen, YC; Enoch, AJ; Holmes, A; Karlsson, RM; Mishina, M; Palachick, B | 1 |
Ballantyne, P; Huang, XF; Newell, K; Nguyen, V; Zavitsanou, K | 1 |
Elliott, JJ; Harte, MK; Jenkins, TA; McKibben, CE; Reynolds, GP | 1 |
Hori, E; Maior, R; Maior, RS; Mao, CV; Nishijo, H; Ono, T | 1 |
Di Marzo, V; Guidali, C; Parolaro, D; Petrosino, S; Realini, N; Rubino, T; Vigano, D | 1 |
Elsworth, JD; Jentsch, JD; Roth, RH; Sanchez, D | 1 |
Hu, G; Li, M; Sun, T | 1 |
Fejgin, K; Finnerty, N; Klamer, D; Lowry, J; Pålsson, E; Wass, C | 1 |
He, W; Li, M; Mead, A | 1 |
Idris, NF; McLean, SL; Neill, JC; Woolley, ML | 1 |
Hareyama, N; Ichinose, H; Ikeda, K; Kurokawa, T; Mochizuki, H; Nakajima, M; Nakao, K; Yoshikawa, S | 1 |
Broberg, BV; Dias, R; Glenthøj, BY; Larsen, DB; Olsen, CK | 1 |
Arai, H; Itoh, M; Liu, J; Matsubara, Y; Namba, T; Seki, T; Suzuki, T; Tanimura, A | 1 |
Feldon, J; Singer, P; Yee, BK | 1 |
Mouri, A; Nabeshima, T; Noda, Y; Waki, Y | 1 |
Adams, W; Ayton, S; van den Buuse, M | 1 |
McLean, SL; Neill, JC; Thomas, D; Woolley, ML | 1 |
Bolognani, F; Botta, P; Bullock, WM; Perrone-Bizzozero, NI; Valenzuela, CF | 1 |
Fujita, Y; Hashimoto, K; Ishima, T; Iyo, M; Kohno, M; Takatsu, Y; Tanibuchi, Y | 1 |
Bürki, H; Fendt, M; Hölscher, C; Imobersteg, S; Leslie, JC; McAllister, K; Shaw, D; van der Putten, H | 1 |
Cai, W; Chen, X; Cheng, J; Guo, Y; Jin, G; Yang, Y; Zhang, H; Zhen, X | 1 |
Dias, R; Goetghebeur, P; Pedersen, CS | 1 |
Arnt, J; Bang-Andersen, B; Brennum, LT; Grayson, B; Idris, N; Neill, J; Witten, LM | 1 |
Fadda, P; Fattore, L; Fratta, W; Frau, R; Spano, MS | 1 |
Boules, M; Li, Z; Peris, J; Richelson, E; Williams, K | 1 |
Danysz, W; Gravius, A; Pietraszek, M; Schlumberger, C | 1 |
Bahn, S; Cheng, TM; Guest, PC; Harris, LW; Lió, P; Lu, YE; Ma, D; Rahmoune, H; Stelzhammer, V; Umrania, Y; Wang, L; Wayland, MT | 1 |
Chen, J; Li, M; Wang, Z | 1 |
Harte, MK; Jenkins, TA; Reynolds, GP | 1 |
Dwyer, DM; Gilmour, G; Lydall, ES | 1 |
Binelli, G; Di Marzo, V; Guidali, C; Parolaro, D; Petrosino, S; Realini, N; Rubino, T; Viganò, D; Zamberletti, E | 1 |
Bian, SZ; Gu, ZL; Jiang, XG; Liu, WL; Sun, ZH; Zhang, J | 1 |
Bastlund, JF; Broberg, BV; Fejgin, K; Glenthøj, BY; Oranje, B; Plath, N | 1 |
Amitai, N; Markou, A | 1 |
Auclair, AL; Bardin, L; Colpaert, FC; Depoortère, R; Newman-Tancredi, A; Vacher, B | 1 |
Boules, M; Gordillo, A; Li, S; Li, Z; Richelson, E; Williams, K | 1 |
Guo, L; Hanig, JP; Liu, F; Patterson, TA; Paule, MG; Qian, F; Sadovova, N; Shi, L; Slikker, W; Wang, C; Wen, Z; Zhang, X; Zou, X | 1 |
Dias, R; Goetghebeur, PJ; Lerdrup, L; Sylvest, A | 1 |
Klamer, D; Lowry, J; Pålsson, E | 1 |
Dawson, N; McVie, A; Morris, BJ; Pratt, JA; Thompson, RJ; Thomson, DM | 1 |
McVie, A; Morris, BJ; Pratt, JA; Thomson, DM | 1 |
Damgaard, T; Hansen, SL; Neill, JC; Plath, N | 1 |
Cole, S; Grayson, B; Idris, NF; Neill, JC; Sood, P; Young, AM | 1 |
Basu, AC; Benneyworth, MA; Coyle, JT; Roseman, AS | 1 |
Alkam, T; Aoyama, Y; Hiramatsu, M; Kim, HC; Mamiya, T; Nabeshima, T; Nitta, A; Yamada, K | 1 |
Nabeshima, T | 1 |
Nishikawa, T | 2 |
Krolikowski, KA; Neale, JH; Olszewski, RT; Profaci, CP | 1 |
Dawson, N; Higham, DJ; Macintyre, L; Morris, BJ; Pratt, JA; Watson, DG; Xiao, X | 1 |
Boyette-Davis, J; Fuchs, PN | 1 |
Elsworth, JD; Hajszan, T; Leranth, C; Roth, RH | 1 |
Adell, A; Jiménez-Sánchez, L; López-Gil, X; Romón, T | 1 |
Ericson, M; Götesson, J; Pickering, C; Söderpalm, B | 1 |
Hou, J; Kristiansen, LV; Owczarek, S; Secher, T | 1 |
Hrupka, B; Pemberton, DJ; Pollard, M; Shaban, H; Steckler, T; Varin, C | 1 |
Bruun, AT; Bundgaard, C; de Jong, IE; Didriksen, M; Elster, L; Frederiksen, K; Larsen, PH; Redrobe, JP; Smith, GP | 1 |
Gendle, DF; Grayson, B; Idris, NF; Lesage, AS; Mackie, C; McLean, SL; Neill, JC; Pemberton, DJ | 1 |
Hammond, B; Hussain, I; Kew, JN; Stean, TO; Upton, N; Virley, DJ; Waters, KA | 1 |
Bzdega, T; Neale, JH; Olszewski, RT | 1 |
Domino, EF; Luby, ED | 1 |
Aerts, N; Alsaif, M; Amess, B; Bahn, S; Ernst, A; Guest, PC; Harris, LW; Lenaerts, I; Martins-de-Souza, D; Peeters, PJ; Rahmoune, H | 1 |
McGregor, C; Roseman, AS; Thornton, JE | 1 |
Mattsson, A; Olson, L; Savage, S | 1 |
Bolton, MM; Heaney, CF; Kinney, JW; Magcalas, CM; Murtishaw, AS; Sabbagh, JJ | 1 |
Bzdega, T; Moffett, JR; Neale, JH; Olszewski, RT; Zuo, D | 1 |
Fujita, Y; Hashimoto, K; Horio, M | 1 |
Bahn, S; Ernst, A; Garcia-Perez, I; Guest, PC; Holmes, E; Kluge, W; Ma, D; Sarnyai, Z; Schwarz, E; Tsang, TM | 1 |
Bradaia, A; Bruns, A; Buchy, D; Chaboz, S; Galley, G; Groebke Zbinden, K; Hoener, MC; Kilduff, TS; Metzler, V; Morairty, SR; Moreau, JL; Mory, R; Norcross, RD; Pouzet, B; Revel, FG; Risterucci, C; Tuerck, D; Wallace, TL; Wettstein, JG | 1 |
Aoyama, Y; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Nakajima, A; Suzuki, S; Toriumi, K; Yamada, T | 1 |
Hida, H; Mouri, A; Nabeshima, T; Noda, Y; Ozaki, N; Taniguchi, M; Ukai, A; Yamada, K | 1 |
Doknić, M; Jevtić, G; Petronijević, ND; Popović, V; Radonjić, NV; Stojković, T; Velimirović, M | 1 |
Adelekun, AE; Hannaway, KE; Horiguchi, M; Jayathilake, K; Meltzer, HY | 1 |
Adilijiang, A; He, J; Kong, J; Kong, L; Li, XM; Tan, Q; Wang, H; Wang, J; Zhang, H; Zhang, R; Zhu, S | 1 |
Barzilay, R; Ben-Zur, T; Bren, Z; Gil-Ad, I; Lev, N; Melamed, E; Offen, D; Sadan, O; Taler, M; Tarasenko, I; Uzan, R; Weizman, A | 1 |
Krystal, JH; Moghaddam, B | 1 |
Cadeddu, F; Fadda, P; Fattore, L; Fratta, W; Spano, MS | 1 |
Heresco-Levy, U; Javitt, DC; Umbricht, D; Zukin, SR | 1 |
Broberg, BV; Fabricius, K; Kaalund, SS; Karlsen, AS; Pakkenberg, B; Plath, N; Riise, J; Secher, T | 1 |
Baker, DA; Choi, S; Kong, L; Lutgen, V; Qualmann, K; Resch, J | 1 |
Kapur, S; Seeman, P | 1 |
Cochran, SM; Kennedy, M; McKerchar, CE; Morris, BJ; Pratt, JA; Steward, LJ | 1 |
Furukawa, H; Furukawa, K; Kan, QM; Nabeshima, T; Nagai, T; Noda, Y; Une, T | 1 |
Fulford, A; Lapiz, MD; Marsden, CA; Mason, R; Muchimapura, S; Parker, T | 1 |
Hashimoto, T; Kajimoto, Y; Kitamura, N; Lin, XH; Maeda, K; Murakami, N; Shirakawa, O; Takumi, T | 1 |
Grottick, AJ; Higgins, GA; Le Pen, G; Moreau, JL | 1 |
Gerum, SV; Javitt, DC; Linn, GS; Negi, SS | 1 |
Daenen, EW; Van Ree, JM; Wolterink, G | 1 |
Copolov, DL; Kusljic, S; van den Buuse, M | 1 |
Svensson, TH | 1 |
Elmer, GI; Guard, H; Hercher, E; Sydnor, J; Vogel, MW | 1 |
Markou, A; Spielewoy, C | 1 |
Laurent, V; Podhorna, J | 1 |
Barton, FB; Bukhari, N; Bzdega, T; Kozikowski, AP; Neale, JH; Olszewski, RT; Shamimi-Noori, S; Vicini, S; Wroblewska, B; Wroblewski, JT; Zhou, J | 1 |
Kyosseva, SV | 1 |
Javitt, DC | 1 |
Sams-Dodd, F | 3 |
Cochran, SM; Morris, BJ; Pratt, JA; Reynolds, GP; Reynolds, LM | 1 |
Bielser, T; Jeanneau, K; Künnecke, B; Moreau, JL; Risterucci, C; Schöppenthau, S; von Kienlin, M | 1 |
Mirkovic, S; Stanojlovic, O; Susic, V; Zivanovic, D | 1 |
Baxter, MG; Murphy, ER; Rodefer, JS | 1 |
Barnouin, MC; Chabot, C; Depoortere, R; Griebel, G; Perrault, G; Scatton, B; Terranova, JP | 1 |
Carlson, KM; Wagner, GC | 1 |
Boismenu, R; Davis, M; Goulet, M; Myers, KM; Rusche, J | 1 |
Freund, TF; Haller, J; Ledent, C; Szirmai, M; Varga, B | 1 |
Dursun, SM; Robertson, H; Williams, HJ; Zamzow, CR | 1 |
Didriksen, M; Flagstad, P; Leist, M; Michael-Titus, AT; Penschuck, S | 1 |
Abdul-Monim, Z; Neill, JC; Reynolds, GP | 2 |
Mizoguchi, H; Mouri, A; Nabeshima, T; Noda, Y | 1 |
Arai, H; Liu, J; Namba, T; Seki, T; Suzuki, T; Tanimura, A | 1 |
Barr, AM; Geyer, MA; Markou, A; Powell, SB | 1 |
Almond, SL; Armstrong, EJ; Brandon, NJ; Chiu, CS; Fradley, RL; Heavens, RB; Hutson, PH; Konno, R; Newman, RJ; Rutter, AR | 1 |
Avenet, P; Bergis, OE; Duarte, C; Griebel, G; Gueudet, C; Oury-Donat, F; Pichat, P; Santucci, V; Scatton, B; Steinberg, R; Stemmelin, J; Terranova, JP; Urani, A; Voltz, C | 1 |
Fujimura, K; Murasawa, H; Nakatani, A; Tatsumi, M; Tatsumi, Y; Yamaguchi, K | 1 |
Johnson, KM; Wang, CZ | 1 |
Manaye, KF; O'Neil, J; Perry, DC; Rasmussen, BA; Tizabi, Y | 1 |
Biguet, NF; Mallet, J; Sahagún, M; Tejedor-Real, P | 1 |
Mouri, A; Murai, R; Nabeshima, T; Noda, Y | 1 |
Engel, JA; Fejgin, K; Klamer, D; Pålsson, E; Svensson, L; Wass, C | 1 |
Elsworth, JD; Morrow, BA; Roth, RH | 1 |
Ballmaier, M; Bortolato, M; Gessa, G; Heinz, A; Rizzetti, C; Spano, P; Zoli, M | 1 |
Furukawa, H; Nabeshima, T; Nitta, A; Noda, Y; Wang, D; Zhou, Y | 1 |
Hulick, VC; Turgeon, SM | 1 |
Abekawa, T; Ito, K; Koyama, T; Nakagawa, S | 1 |
Harte, MK; Reynolds, GP | 1 |
Griffey, KI; Johnson, BG; Knitowski, KM; McKinzie, DL; Monn, JA; Perry, KW; Rorick-Kehn, LM; Salhoff, CR; Schoepp, DD; Tizzano, JP; Witkin, JM | 1 |
Javitt, DC; Lifshitz, K; Linn, GS; O'Keeffe, RT; Schroeder, C | 1 |
Huang, XF; Newell, KA; Zavitsanou, K | 1 |
Arnt, J; Didriksen, M; Skarsfeldt, T | 1 |
Harris, AJ; Honey, A; Jones, DN; Jones, GA; Kelly, FM; Kew, JN; Maycox, PR; Melarange, RA; Murdock, PR; Robbins, MJ; Rocheville, M; Rourke, C; Rupniak, T; Soffin, EM; Starr, KR; Strum, J | 1 |
Amitai, N; Markou, A; Semenova, S | 1 |
Deutsch, SI; Kozikowski, AP; Krolikowski, KA; Long, K; Mastropaolo, J; Monteiro, AC; Neale, JH; Olszewski, RT; Wegorzewska, MM; Zhou, J | 1 |
Enomoto, T; Nabeshima, T; Noda, Y | 1 |
Grayson, B; Idris, NF; Neill, JC | 1 |
Mouri, A; Nabeshima, T; Noda, Y | 1 |
Baker, DA; Haroutunian, V; Kristiansen, LV; Madayag, A; Meador-Woodruff, JH; Raju, I | 1 |
Castellano, JM; Dyck, BA; Ki, K; Mishra, RK; Skoblenick, KJ; Thomas, N | 1 |
Austin, NE; Hartfield, EM; Jones, DN; Kalinichev, M; Maycox, PR; Moore, SH; Robbins, MJ; Savage, KM | 1 |
Djuric, D; Hrncić, D; Loncar-Stevanović, H; Rasić, A; Stanojlović, O; Susić, V | 1 |
Nesić, ZI; Paunović, VR; Petronijević, ND; Prostran, MS; Radonjić, NV; Todorović, VR; Vucković, SM | 1 |
Neill, JC; Snigdha, S | 1 |
Johnson, KM; Wang, CZ; Xia, Y; Yang, SF | 1 |
Djurić, D; Hrncić, D; Mladenović, D; Radosavljević, T; Rasić, A; Stanojlović, O; Susić, V; Vucević, D | 1 |
Cochran, SM; Egerton, A; Morris, BJ; Pratt, JA; Winchester, C | 1 |
Broberg, BV; Dias, R; Glenthøj, BY; Olsen, CK | 1 |
Chocyk, A; Fijal, K; Mackowiak, M; Wedzony, K; Zajaczkowski, W | 1 |
Davis, JM; Schlemmer, RF | 1 |
Kogan, MJ; Mulè, SJ; Verebey, K | 1 |
Boren, JL; Consroe, PF | 1 |
Friedmann, T; Goldstein, M; Hunt, M; Jinnah, HA; Langlais, PJ; Lee, KY; Narang, N; Wamsley, JK; Wojcik, BE | 1 |
Goettl, VM; Larson, AA | 1 |
Andersson, JL; Hildebrand, BE; Marcus, M; Mathé, JM; Nomikos, GG; Svensson, TH | 1 |
Ellison, G | 1 |
Kunishima, C; Nabeshima, T; Shibuya, H; Toru, M; Yamada, K; Yoshikawa, T | 1 |
Araki, H; Nakazato, A; Ogawa, S; Okuyama, S; Otomo, S | 1 |
Ellison, G; Switzer, RC | 1 |
Kamenka, JM; Ohanna, F; Pencalet, P; Poulat, P; Privat, A | 1 |
Furukawa, H; Nabeshima, T; Noda, Y; Yamada, K | 1 |
Nabeshima, T; Noda, Y | 2 |
Yamamoto, J | 1 |
Elsworth, JD; Jentsch, JD; Redmond, DE; Roth, RH; Taylor, JR; Youngren, KD | 1 |
Pennisi, E | 1 |
Jentsch, JD; Roth, RH; Taylor, JR | 1 |
Campbell, IG; Feinberg, I | 1 |
Adams, BW; Moghaddam, B | 1 |
Jentsch, JD; Roth, RH | 1 |
Deveney, AM; Jackson, DM; Johansson, C; Reif, D | 1 |
Caron, MG; Gainetdinov, RR; Koller, BH; Mohn, AR | 1 |
Ehrhardt, J; Sabel, BA; Schroeder, U | 1 |
Danysz, W; Karcz-Kubicha, M; Wedzony, K; Zajaczkowski, W | 1 |
Leung, LS; Ma, J | 1 |
Stanojlović, O; Susić, V; Zivanović, D | 1 |
Doat, M; Rabin, RA; Winter, JC | 1 |
Dai, J; Guan, HJ; Zhu, XZ | 1 |
Kanazir, S; Rakic, L; Ruzdijic, S; Veskov, R; Vukosavic, S | 1 |
Feldon, J; Fischer-Colbrie, R; Fleischhacker, WW; Humpel, C; Laslop, A; Marksteiner, J; Weis, C; Weiss, U | 1 |
Bymaster, FP; Felder, CC; Gomeza, J; Hamilton, SE; McKinzie, DL; Nathanson, NM; Porter, AC; Skillman, TL; Wess, J; Zhang, L | 1 |
Gotoh, L; Hirano, M; Hondo, H; Kanchiku, I; Kawanami, N; Kuroki, T; Motomura, K; Nakahara, T; Ohta, E; Uchimura, H | 1 |
Mello, NK | 1 |
Cone, EJ; Gorodetzky, CW; Jasinski, DR; Risner, ME; Shannon, HE; Su, TP; Vaupel, DB | 1 |
Heath, RG | 1 |
Feldon, J; Weiner, I | 1 |
Backhauss, C; Karkoutly, C; Krieglstein, J; Nuglisch, J; Peruche, B; Prehn, JH; Rossberg, C | 1 |
Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
Herrera, DG; Robertson, HA | 1 |
Boxer, PA; Cordon, JJ; Mann, ME; Marcoux, FW; Rock, DM; Rodolosi, LC; Taylor, CP; Vartanian, MG | 1 |
Geyer, MA; Mansbach, RS | 1 |
Olney, JW | 1 |
Backlund, EO; Gerhardt, G; Hoffer, B; Lindvall, O; Olson, L; Rose, G; Seiger, A; Strömberg, I | 1 |
Marquis, KL; Moreton, JE | 1 |
32 review(s) available for phencyclidine and Disease Models, Animal
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The Effect of Inhalant Organic Dust on Bone Health.
Topics: Animals; Bone and Bones; Disease Models, Animal; Dust; Humans; Inhalation Exposure; Mice; Mice, Inbred C57BL | 2018 |
Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.
Topics: Aerosols; Animals; Cough; Disease Models, Animal; Dust; Guinea Pigs; History, 19th Century; History, 20th Century; Humans; Mycobacterium tuberculosis; Research; Sputum; Tuberculosis, Pulmonary | 2018 |
[Influence of environmental factor on allergic conjunctivitis].
Topics: Air Pollutants; Animals; Conjunctivitis, Allergic; Disease Models, Animal; Disease Progression; Dust; Humans; Mice; Particulate Matter; Pollen; Smog; Soil Pollutants; Vehicle Emissions | 2014 |
Heaves, an asthma-like disease of horses.
Topics: Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Cell Proliferation; Disease Models, Animal; Dust; Horse Diseases; Horses; Humans; Neutrophils | 2011 |
Current concepts in the pathogenesis of occupationally induced allergic pneumonitis.
Topics: Alveolitis, Extrinsic Allergic; Animals; Antibody Formation; Disease Models, Animal; Dust; Granuloma; Humans; Immunoglobulin Heavy Chains; Inflammation; Leukocytes; Mice; Mice, Inbred Strains; Occupational Diseases | 1987 |
Louis E. Siltzbach Memorial Lecture. Concepts of pathogenesis and lung reactivity in hypersensitivity pneumonitis.
Topics: Acute Disease; Alveolitis, Extrinsic Allergic; Animals; Bird Fancier's Lung; Chronic Disease; Disease Models, Animal; Dust; Farmer's Lung; Guinea Pigs; Humans; Immunization; Lung; Macaca mulatta; Pulmonary Alveoli; Rabbits; T-Lymphocytes | 1986 |
[Alveolar proteinosis].
Topics: Animals; Cricetinae; Disease Models, Animal; Dust; Freund's Adjuvant; Guinea Pigs; Humans; Injections, Intravenous; Macrophages; Methods; Pulmonary Alveolar Proteinosis; Rabbits; Rats; Silicon Dioxide | 1972 |
Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors.
Topics: Adenylyl Cyclases; Animals; Behavior, Animal; Disease Models, Animal; Gene-Environment Interaction; Humans; Mice; Nerve Tissue Proteins; Neuregulin-1; Nuclear Receptor Subfamily 4, Group A, Member 2; Peptides; Phencyclidine; Phenotype; Point Mutation; Schizophrenia; Schizophrenic Psychology | 2013 |
The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Topics: Animals; Disease Models, Animal; Hippocampus; Humans; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Rats; Schizophrenia | 2013 |
Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Disease Models, Animal; Humans; Indophenol; Phencyclidine; Prefrontal Cortex; Schizophrenia; Schizophrenic Psychology; Thalamic Nuclei | 2013 |
Prefrontal dysfunction and a monkey model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Haplorhini; Phencyclidine; Prefrontal Cortex; Psychomotor Performance; Schizophrenia | 2015 |
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.
Topics: Animals; Attention; Cognition Disorders; Disease Models, Animal; Male; Phencyclidine; Rats; Reversal Learning; Schizophrenia | 2015 |
The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Enzyme Inhibitors; Humans; Ketamine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phencyclidine; Schizophrenia | 2016 |
[Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists].
Topics: Animals; Disease Models, Animal; Evidence-Based Medicine; Humans; Mice; Mice, Transgenic; Nerve Tissue Proteins; Phencyclidine; Phencyclidine Abuse; Polymorphism, Single Nucleotide; Psychiatry; Schizophrenia | 2009 |
[Receptor antagonist of NMDA and animal models of schizophrenia].
Topics: Animals; Behavior, Animal; Brain; Consciousness Disorders; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Humans; Ketamine; Mice; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2009 |
Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.
Topics: Animals; Choice Behavior; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Neuropsychological Tests; Phencyclidine; Reaction Time; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2010 |
Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cerebral Cortex; Disease Models, Animal; Dopamine; Emotions; Glutamic Acid; Humans; Ketamine; Neurosciences; Phencyclidine; Psychoses, Substance-Induced; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synapses; Translational Research, Biomedical | 2012 |
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Brain; Brain Mapping; Cerebral Cortex; Cognition Disorders; Contingent Negative Variation; Disease Models, Animal; Drug Synergism; Glycine; Hippocampus; Humans; Ketamine; Perception; Phencyclidine; Psychoses, Substance-Induced; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission | 2012 |
[Genetic study on schizophrenia and its recurrence utilizing pharmacological models].
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Disease Models, Animal; Dopamine Agents; Humans; Ketamine; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Recurrence; Schizophrenia | 2002 |
Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Humans; Mood Disorders; Phencyclidine; Receptors, Adrenergic, alpha; Schizophrenia | 2003 |
The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia.
Topics: Animals; Cerebellum; Disease Models, Animal; Humans; Mitogen-Activated Protein Kinases; Neurons; Phencyclidine; Schizophrenia; Signal Transduction | 2004 |
Glutamate as a therapeutic target in psychiatric disorders.
Topics: Animals; Disease Models, Animal; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Phencyclidine; Receptors, Glutamate; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2004 |
[Dysfunction of glutamatergic systems and potential animal models of schizophrenia].
Topics: Animals; Disease Models, Animal; Glutamates; Mice; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Signal Transduction | 2006 |
[Update on the animal models of schizophrenia].
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Drug Design; Excitatory Amino Acid Antagonists; Glycine; Humans; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serine | 2006 |
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cognition; Disease Models, Animal; Glutamic Acid; Mice; Motor Activity; Phencyclidine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Signal Transduction | 2006 |
Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
Topics: Animals; Behavior, Animal; Calcineurin; Cognition; Disease Models, Animal; Gait; Glutamic Acid; Humans; Inhibition, Psychological; Mice; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Neuregulin-1; Phencyclidine; Receptors, Lysophosphatidic Acid; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2007 |
[Behavioral evaluation in animal models of schizophrenia].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Learning; Mice; Phencyclidine; Schizophrenia | 2007 |
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Humans; Phencyclidine; Prefrontal Cortex; Psychoses, Substance-Induced; Schizophrenia | 2008 |
The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.
Topics: Animals; Behavior, Animal; Dementia; Disease Models, Animal; Dizocilpine Maleate; Humans; Ketamine; Phencyclidine; Receptors, N-Methyl-D-Aspartate | 1995 |
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
Topics: Animals; Brain Chemistry; Cognition; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Humans; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 1999 |
Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Neural Networks, Computer; Phencyclidine; Psychotic Disorders; Rats; Reproducibility of Results; Schizophrenia; Social Behavior Disorders; Stereotyped Behavior | 1999 |
2 trial(s) available for phencyclidine and Disease Models, Animal
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging.
Topics: Age Factors; Animals; Animals, Newborn; Blood Gas Analysis; Blood Volume; Brain; Brain Mapping; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Magnetic Resonance Imaging; Male; Multivariate Analysis; Phencyclidine; Rats; Schizophrenia; Time Factors | 2013 |
438 other study(ies) available for phencyclidine and Disease Models, Animal
Article | Year |
---|---|
A suitable silicosis mouse model was constructed by repeated inhalation of silica dust via nose.
Topics: Administration, Inhalation; Animals; Disease Models, Animal; Dust; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pulmonary Fibrosis; Silicon Dioxide; Silicosis | 2021 |
The effects of BRL-50481 on ovalbumin-induced asthmatic lung inflammation exacerbated by co-exposure to Asian sand dust in the murine model.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 7; Cytokines; Disease Models, Animal; Dust; Fluorescent Antibody Technique; Inhalation Exposure; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Pneumonia; Sand | 2022 |
Vitamin D3 suppresses astrocyte activation and ameliorates coal dust-induced mood disorders in mice.
Topics: Animals; Anxiety; Astrocytes; Brain-Derived Neurotrophic Factor; Cholecalciferol; Coal; Depression; Disease Models, Animal; Dust; Hippocampus; Humans; Mice; Mood Disorders; Pneumoconiosis | 2022 |
Co-exposure of peptidoglycan and heat-inactivated Asian sand dust exacerbates ovalbumin-induced allergic airway inflammation in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Wall; Cytokines; Disease Models, Animal; Dust; Hot Temperature; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Peptidoglycan; Sand | 2022 |
Inflammation and fibrosis in the coal dust-exposed lung described by confocal Raman spectroscopy.
Topics: Animals; Anthracosis; bcl-2-Associated X Protein; Coal; Coal Mining; Disease Models, Animal; Dust; Fibrosis; Inflammation; Ki-67 Antigen; Lung; Mice; Minerals; Pneumoconiosis; Spectrum Analysis, Raman | 2022 |
A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust.
Topics: Animals; Disease Models, Animal; Dust; Humans; Lung; Mice; Pulmonary Alveoli; Silicon Dioxide; Silicosis | 2023 |
Particulate Matter, Asian Sand Dust Delays Cyclophosphamide-induced Type 1 Diabetes in NOD Mice.
Topics: Animals; Cyclophosphamide; Cytokines; Diabetes Mellitus, Type 1; Disease Models, Animal; Disease Susceptibility; Dust; Female; Immunomodulation; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred NOD; Particulate Matter; Sand; Spleen; T-Lymphocytes, Regulatory | 2020 |
Therapeutic effects of shibashin misena® against fine-dust-induced pulmonary disorders in mice.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Cytokines; Disease Management; Disease Models, Animal; Disease Susceptibility; Dust; Functional Food; Immunohistochemistry; Inflammation Mediators; Lung Diseases; Mice; Particulate Matter; Pulmonary Fibrosis | 2020 |
A High Docosahexaenoic Acid Diet Alters the Lung Inflammatory Response to Acute Dust Exposure.
Topics: Animal Feed; Animals; Arachidonic Acid; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Docosahexaenoic Acids; Dust; Inhalation Exposure; Lung; Male; Mice; Mice, Inbred C57BL; Pneumonia; Swine | 2020 |
Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation.
Topics: Animals; Antibodies; Asthma; Cross Reactions; Disease Models, Animal; Dust; Humans; Inflammation; Neutrophils; Phosphopyruvate Hydratase; Pyroglyphidae | 2021 |
Standardized herbal extract PM014 alleviates fine dust-induced lung inflammation in mice.
Topics: Animals; Disease Models, Animal; Dust; Female; Inhalation Exposure; Mice; Mice, Inbred C57BL; Plant Extracts; Pneumonia; Republic of Korea | 2020 |
Isolation and Identification of Pathogenic Acanthamoeba Species from Air Conditioning Systems, Egypt.
Topics: Acanthamoeba; Air Conditioning; Amebiasis; Animals; Disease Models, Animal; Dust; Egypt; Equipment Contamination; Humans; Mice; Polymerase Chain Reaction; RNA, Ribosomal, 18S | 2021 |
Biological effects of inhaled hydraulic fracturing sand dust. II. Particle characterization and pulmonary effects 30 d following intratracheal instillation.
Topics: Air Pollutants, Occupational; Animals; Disease Models, Animal; Dust; Hydraulic Fracking; Inhalation Exposure; Lung; Male; Occupational Exposure; Pneumonia; Quartz; Rats; Rats, Sprague-Dawley; Sand; Silicon Dioxide; Silicosis; Trachea | 2020 |
Pre-exposure to hydrogen sulfide modulates the innate inflammatory response to organic dust.
Topics: Animals; Disease Models, Animal; Dust; Humans; Hydrogen Sulfide; Inflammation; Mice | 2021 |
High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Disease Models, Animal; Dust; High-Throughput Screening Assays; Inflammation; Inflammation Mediators; Lung; Lung Diseases; Macrophages; Male; Mice; Mice, Inbred DBA; Monocytes; Myeloid-Derived Suppressor Cells; Neutrophils | 2021 |
Mine-site derived particulate matter exposure exacerbates neurological and pulmonary inflammatory outcomes in an autoimmune mouse model.
Topics: Air Pollutants; Animals; Arizona; Autoimmune Diseases; Biomarkers; Disease Models, Animal; Dust; Encephalitis; Female; Inhalation Exposure; Learning; Memory; Mice; Mining; New Mexico; Particle Size; Particulate Matter; Pneumonia; Random Allocation | 2021 |
Organic dust-induced mitochondrial dysfunction could be targeted via cGAS-STING or cytoplasmic NOX-2 inhibition using microglial cells and brain slice culture models.
Topics: Animals; Bacterial Proteins; Brain; Disease Models, Animal; Dust; Mice; Microglia; Mitochondria; NADH, NADPH Oxidoreductases; Signal Transduction | 2021 |
Effects of elevated CO
Topics: Air Pollution, Indoor; Animals; Carbon Dioxide; Disease Models, Animal; Dust; Environmental Monitoring; Female; Inhalation Exposure; Lipopolysaccharides; Mice; Mice, Inbred C57BL | 2021 |
A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts.
Topics: Agricultural Workers' Diseases; Animals; Bronchoalveolar Lavage Fluid; Diet; Disease Models, Animal; Docosahexaenoic Acids; Dust; Eicosapentaenoic Acid; Endocannabinoids; Fatty Acids, Unsaturated; Inflammation; Inhalation Exposure; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Respiratory Tract Diseases; Swine; Tumor Necrosis Factor-alpha | 2021 |
Dust induces lung fibrosis through dysregulated DNA methylation.
Topics: Animals; Anthracosis; Cell Line; Coal; Coal Mining; Collagen Type I; Collagen Type III; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dust; Epigenesis, Genetic; Humans; Male; Occupational Exposure; Particle Size; Pulmonary Fibrosis; Rats, Sprague-Dawley; Silicon Dioxide | 2019 |
Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by a RORγt inverse agonist.
Topics: Animals; Asthma; Disease Models, Animal; Dust; Hypersensitivity; Inflammation; Interleukin-17; Lung; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Pneumonia; Respiratory Hypersensitivity; Th17 Cells | 2019 |
Free radical oxidation in rats in the delayed period after combined exposure to dust and radiation.
Topics: Adaptation, Physiological; Adrenal Glands; Animals; Animals, Outbred Strains; Asbestos; Carcinogens; Disease Models, Animal; Dust; Free Radicals; Humans; Lipid Peroxidation; Liver; Lymph Nodes; Male; Malondialdehyde; Occupational Exposure; Organ Specificity; Oxidation-Reduction; Oxidative Stress; Radioactive Pollutants; Rats; Spleen; Thymus Gland | 2013 |
Evaluation of the deposition, translocation and pathological response of brake dust with and without added chrysotile in comparison to crocidolite asbestos following short-term inhalation: interim results.
Topics: Animals; Asbestos, Crocidolite; Asbestos, Serpentine; Asbestosis; Chemical Phenomena; Disease Models, Animal; Dust; Half-Life; Industry; Inhalation Exposure; Lung; Male; Materials Testing; Motor Vehicles; Occupational Diseases; Protective Devices; Rats; Rats, Wistar; Respiratory Mucosa; Tissue Distribution; Toxicity Tests, Acute | 2014 |
Shifted T-cell polarisation after agricultural dust exposure in mice and men.
Topics: Agriculture; Animals; Bronchial Provocation Tests; Disease Models, Animal; Dust; Environmental Exposure; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunoglobulin E; Inflammation; Interleukin-17; Interleukin-1beta; Interleukin-6; Lung; Mice; Mice, Inbred BALB C; Pyroglyphidae; T-Lymphocytes; Th1 Cells; Th2 Cells | 2014 |
Aggravation of ovalbumin-induced murine asthma by co-exposure to desert-dust and organic chemicals: an animal model study.
Topics: Air Pollutants; Animals; Asthma; Disease Models, Animal; Dust; Lung; Male; Mice; Mice, Inbred ICR; Ovalbumin; Pulmonary Eosinophilia; Specific Pathogen-Free Organisms; Tars | 2014 |
Influence of Asian dust particles on immune adjuvant effects and airway inflammation in asthma model mice.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Dust; Inflammation; Japan; Male; Mice; Respiratory System | 2014 |
The omega-3 fatty acid docosahexaenoic acid attenuates organic dust-induced airway inflammation.
Topics: Air Pollutants; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Dust; Epithelial Cells; Fibroblasts; Humans; Inflammation Mediators; Inhalation Exposure; Intercellular Adhesion Molecule-1; Lung; Male; Mice, Inbred C57BL; Monocytes; Neutrophil Infiltration; Pneumonia; Swine | 2014 |
Farm animal models of organic dust exposure and toxicity: insights and implications for respiratory health.
Topics: Animal Husbandry; Animals; Disease Models, Animal; Dust; Humans; Inflammation; Inhalation Exposure; Lung Diseases; Oxidative Stress; Swine | 2015 |
Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust.
Topics: Agricultural Workers' Diseases; Air Pollutants, Occupational; Animal Husbandry; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Dust; Humans; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Organic Chemicals; Particulate Matter; Pneumonia; Sus scrofa; Translational Research, Biomedical | 2015 |
CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice.
Topics: Animal Husbandry; Animals; Bronchoalveolar Lavage Fluid; Chemokines; Chemokines, CXC; Cytokines; Disease Models, Animal; Dust; Inflammation; Inflammation Mediators; Interleukin-8; Mice; Occupational Diseases; Peptide Fragments; Protein Kinase C; Swine | 2015 |
Extracellular vesicles derived from Gram-negative bacteria, such as Escherichia coli, induce emphysema mainly via IL-17A-mediated neutrophilic inflammation.
Topics: Air Pollution, Indoor; Animals; Cell-Derived Microparticles; Disease Models, Animal; Dust; Escherichia coli; Extracellular Space; Interferon-gamma; Interleukin-17; Lipopolysaccharides; Macrophages, Alveolar; Mice; Mice, Knockout; Neutrophils; Phenotype; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Toll-Like Receptors | 2015 |
Pathogenesis sequences in Gejiu miners with lung cancer: an introduction.
Topics: Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; China; Coal; Disease Models, Animal; Dust; Epithelial Cells; Fibroblasts; Humans; Lung Neoplasms; Miners; Occupational Exposure; Rats | 2015 |
[Study on the therapeutic effects of tetrandrine combined with N-acetylcysteine on experimental silicosis of rats].
Topics: Acetylcysteine; Animals; Benzylisoquinolines; Disease Models, Animal; Dust; Hydroxyproline; Interleukin-6; Lung; Malondialdehyde; Pulmonary Fibrosis; Quartz; Rats; Rats, Wistar; Silicon Dioxide; Silicosis; Tumor Necrosis Factor-alpha | 2015 |
Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone Loss.
Topics: Air Pollutants; Animals; Bone Diseases, Metabolic; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Disease Models, Animal; Dust; Inhalation Exposure; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Osteoclasts; Osteogenesis; Pneumonia; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Tibia; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2016 |
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children.
Topics: Adaptor Proteins, Vesicular Transport; Adolescent; Agriculture; Animals; Asthma; Child; Christianity; Cross-Sectional Studies; Cytokines; Disease Models, Animal; Dust; Environmental Exposure; Female; Gene Expression; Humans; Immunity, Innate; Immunoglobulin E; Leukocyte Count; Leukocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Animal; Myeloid Differentiation Factor 88; Prevalence | 2016 |
Effects of Asian Dust Particles on the Early-Stage Antigen-Induced Immune Response of Asthma in NC/Nga Mice.
Topics: Allergens; Animals; Asia; Asthma; Dermatophagoides farinae; Disease Models, Animal; Dust; Inflammation; Mice; Mice, Inbred BALB C; Receptors, Leukotriene; Respiratory System | 2016 |
Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust.
Topics: Animals; Biomarkers; Bone Marrow Cells; Bone Resorption; Cytokines; Disease Models, Animal; Dust; Inflammation Mediators; Inhalation Exposure; Interleukin-6; Lung; Male; Mice; Mice, Knockout; Osteoclasts; Signal Transduction; X-Ray Microtomography | 2017 |
The time-dependent health and biochemical effects in rats exposed to stainless steel welding dust and its soluble form.
Topics: Air Pollutants, Occupational; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dust; Inhalation Exposure; Lung Injury; Male; Rats; Rats, Wistar; Stainless Steel; Welding | 2017 |
Bakery flour dust exposure causes non-allergic inflammation and enhances allergic airway inflammation in mice.
Topics: Animals; Asthma; Bronchoalveolar Lavage; Cytokines; Disease Models, Animal; Dust; Flour; Immunoglobulin E; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Occupational Diseases; Ovalbumin; Toll-Like Receptor 4 | 2008 |
Intranasal organic dust exposure-induced airway adaptation response marked by persistent lung inflammation and pathology in mice.
Topics: Adaptation, Physiological; Animals; Antigen-Presenting Cells; Bronchial Hyperreactivity; Disease Models, Animal; Dust; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Occupational Diseases; Phagocytosis; Pneumonia; Respiratory Mucosa; Swine | 2009 |
Amelioration of pathology by ELR-CXC chemokine antagonism in a swine model of airway endotoxin exposure.
Topics: Animals; Chemokines, CXC; Disease Models, Animal; Dust; Endotoxins; Environmental Exposure; Inflammation; Interleukin-8; Lipopolysaccharides; Lung; Peptide Fragments; Sodium Chloride; Swine | 2009 |
Fractionation of swine barn dust and assessment of its impact on the respiratory tract following repeated airway exposure.
Topics: Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Disease Models, Animal; Dust; Enzyme-Linked Immunosorbent Assay; Housing, Animal; Inflammation; Inhalation Exposure; Interleukin-1beta; Interleukin-6; Methacholine Chloride; Mice; Plethysmography; Respiratory System; Risk Assessment; Swine; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization.
Topics: Animals; Bronchial Hyperreactivity; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Dust; Female; Galactans; Immunologic Factors; Interleukin-10; Mice; Mice, Inbred BALB C; Poaceae; Respiratory System | 2010 |
Pathological study of acute pulmonary toxicity induced by intratracheally instilled Asian sand dust (kosa).
Topics: Acute Lung Injury; Animals; Asia; Bronchioles; Cytokines; Disease Models, Animal; Dust; Elements; Epithelial Cells; Intubation, Intratracheal; Lung; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; Oxidative Stress; Particle Size; Pulmonary Alveoli; Silicon Dioxide | 2010 |
A critical role for C5L2 in the pathogenesis of experimental allergic asthma.
Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cell Communication; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Dust; Inflammation Mediators; Interleukin-17; Mice; Mice, Inbred BALB C; Mice, Knockout; Ovalbumin; Pyroglyphidae; Receptor, Anaphylatoxin C5a; Receptors, Chemokine; Th1 Cells | 2010 |
Toll-like receptor 2 regulates organic dust-induced airway inflammation.
Topics: Animal Husbandry; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Chemokines; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Dust; Housing, Animal; Inflammation Mediators; Inhalation Exposure; Lipopolysaccharides; Lung; Macrophages, Alveolar; Methacholine Chloride; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Nitric Oxide; Peptidoglycan; Pneumonia; Swine; Time Factors; Toll-Like Receptor 2 | 2011 |
[The comparative study of quartz dust and bleomycin-induced pulmonary fibrosis in rats].
Topics: Animals; Bleomycin; Disease Models, Animal; Dust; Female; Lung; Pulmonary Fibrosis; Quartz; Rats; Rats, Wistar | 2011 |
The feline thyroid gland: a model for endocrine disruption by polybrominated diphenyl ethers (PBDEs)?
Topics: Animal Feed; Animals; Cat Diseases; Cats; Disease Models, Animal; Dust; Endocrine Disruptors; Environmental Exposure; Environmental Pollutants; Flame Retardants; Food Contamination; Halogenated Diphenyl Ethers; Hyperthyroidism; Pilot Projects; Surveys and Questionnaires; Thyroid Function Tests; Thyrotropin; Thyroxine | 2012 |
Effect of Asian sand dust on mucin production in NCI-H292 cells and allergic murine model.
Topics: Animals; Cell Culture Techniques; Disease Models, Animal; Dust; Epithelial Cells; Female; Humans; Hypersensitivity; Mice; Mice, Inbred BALB C; Mucin 5AC; Ovalbumin; Respiratory Mucosa; Silicon Dioxide; Transforming Growth Factor alpha | 2012 |
Alcohol exposure alters mouse lung inflammation in response to inhaled dust.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Chemokines; Disease Models, Animal; Dust; Epithelial Cells; Ethanol; Female; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; Pneumonia; Protein Kinase C; Trachea; Tumor Necrosis Factor-alpha | 2012 |
Protein kinase C epsilon is important in modulating organic-dust-induced airway inflammation.
Topics: Animals; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chemokines; Disease Models, Animal; Dust; Environmental Exposure; Enzyme Activation; Female; Inflammation Mediators; Lung; Male; Methacholine Chloride; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Protein Kinase C-epsilon; T-Lymphocytes | 2012 |
Proteolytic activity in cowshed dust extracts induces C5a release in murine bronchoalveolar lavage fluids which may account for its protective properties in allergic airway inflammation.
Topics: Animals; Asthma; Biopsy, Needle; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cattle; Chemotaxis; Complement C5; Cytokines; Disease Models, Animal; Dust; Enzyme-Linked Immunosorbent Assay; Female; Hypersensitivity; Immunohistochemistry; Immunologic Factors; Inflammation; Mice; Mice, Inbred BALB C; Proteolysis; Random Allocation; Sensitivity and Specificity | 2013 |
Vitamin D treatment modulates organic dust-induced cellular and airway inflammatory consequences.
Topics: Administration, Intranasal; Animals; Cell Line; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Disease Models, Animal; Dust; Humans; In Vitro Techniques; Inflammation; Interleukin-8; Lung; Male; Mice; Mice, Inbred C57BL; Monocytes; Organic Agriculture; Protein Kinase C; Swine; Toll-Like Receptor 2; Toll-Like Receptor 4; Vitamin D | 2013 |
Murine strain differences in airway inflammation induced by diesel exhaust particles and house dust mite allergen.
Topics: Animals; Antigens, Dermatophagoides; Asthma; Chemokine CCL11; Chemokine CCL5; Chemokines, CC; Cytokines; Disease Models, Animal; Dust; Glycoproteins; Housing; Lung; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Respiratory Hypersensitivity; Species Specificity; Vehicle Emissions | 2002 |
Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Models, Animal; Dust; Edible Grain; Gene Expression; Lipopolysaccharides; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Occupational Exposure; Pneumonia; Pulmonary Surfactant-Associated Protein A; Receptors, Cell Surface; Respiratory Mucosa; Signal Transduction; Toll-Like Receptors | 2003 |
Optimization of route of administration for coexposure to ovalbumin and particle matter to induce adjuvant activity in respiratory allergy in the mouse.
Topics: Administration, Intranasal; Aerosols; Air Pollutants; Animals; Bronchoalveolar Lavage; Disease Models, Animal; Drug Interactions; Dust; Eosinophils; Hypersensitivity; Immunoglobulin E; Inflammation; Infusions, Parenteral; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Particle Size; Vehicle Emissions | 2003 |
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling.
Topics: Airway Resistance; Allergens; Animals; Asthma; Biopsy, Needle; Bronchial Hyperreactivity; Chronic Disease; Cytokines; Disease Models, Animal; Dust; Female; Immunoglobulins; Immunohistochemistry; Inflammation; Inflammation Mediators; Mice; Mice, Inbred BALB C; Mites; Probability; Pulmonary Eosinophilia; Sensitivity and Specificity | 2004 |
Dust mite-induced asthma in cynomolgus monkeys.
Topics: Adenosine; Aerosols; Allergens; Animals; Asthma; Bronchial Provocation Tests; Cytokines; Disease Models, Animal; Dust; Histamine; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunization; Immunoglobulin E; Immunoglobulin G; Lung; Macaca fascicularis; Mites; Respiratory Function Tests; Respiratory Hypersensitivity; Respiratory System; Th2 Cells; Time Factors | 2004 |
[The model of mouse lung tumor short-term induction test for assaying the carcinogencity induced by extracts of birch wood dust].
Topics: Animals; Betula; Disease Models, Animal; Dust; Lung Neoplasms; Mice; Plant Extracts; Wood | 2002 |
[Study on making pneumoconiosis model and method of lung lavage in rabbit].
Topics: Animals; Bronchoalveolar Lavage; Coal; Disease Models, Animal; Dust; Lung; Pneumoconiosis; Rabbits; Silicon Dioxide | 2002 |
Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust.
Topics: Acute Disease; Animals; Asthma; Bronchial Hyperreactivity; Dexamethasone; Disease Models, Animal; Dust; Eosinophils; Female; Glucocorticoids; Immunoglobulin E; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; Neutrophils; Pneumonia | 2004 |
Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism.
Topics: Administration, Intranasal; Allergens; Animals; Antigens, Dermatophagoides; Arthropod Proteins; Cells, Cultured; Cysteine Endopeptidases; Dermatophagoides pteronyssinus; Disease Models, Animal; Dust; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Immune Sera; Inflammation; Lung; Mice; Mice, Inbred BALB C; Recombinant Proteins; Respiratory Hypersensitivity; Th2 Cells | 2004 |
Dose dependency of adjuvant activity of particulate matter from five European sites in three seasons in an ovalbumin-mouse model.
Topics: Adjuvants, Immunologic; Air Pollutants; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Dust; Enzyme-Linked Immunosorbent Assay; Europe; Immunoglobulin E; Immunoglobulin G; L-Lactate Dehydrogenase; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Particle Size; Respiratory Hypersensitivity; Seasons; Solubility | 2005 |
A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Dose-Response Relationship, Drug; Dust; Histamine; Mites; Phosphodiesterase Inhibitors; Purines; Rabbits; Radioligand Assay; Receptor, Adenosine A1 | 2005 |
[Cell reactions to amber: amber lung in experimental animals].
Topics: Amber; Animals; Disease Models, Animal; Dust; Humans; Lung; Occupational Diseases | 2006 |
[Experimental study of effects induced in thyroid gland by manganese-containing dust].
Topics: Air Pollutants; Animals; Biomarkers; Disease Models, Animal; Dust; Manganese; Manganese Poisoning; Nitric Oxide; Radioimmunoassay; Rats; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Thyrotropin | 2005 |
CXC chemokines modulate IgE secretion and pulmonary inflammation in a model of allergic asthma.
Topics: Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Chemokines; Chemokines, CXC; Disease Models, Animal; Dust; Female; Immunoglobulin E; Inflammation; Lung; Mice; Mice, Inbred BALB C | 2005 |
[Biochemical and physiologic parameters in experimental animals subjected to complex of occupational factors].
Topics: Animals; Biomarkers; Calcium Channels; Catalase; Disease Models, Animal; Dust; Male; Muscle, Skeletal; Occupational Diseases; Occupational Exposure; Rats | 2006 |
Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice.
Topics: Acetates; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Choline; Cockroaches; Complement C5; Cyclopropanes; Disease Models, Animal; Dust; Genetic Predisposition to Disease; Immunoglobulin E; Interleukin-12; Leukotriene Antagonists; Leukotrienes; Mice; Mice, Knockout; Quinolines; Respiratory Hypersensitivity; Sulfides | 2006 |
Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma.
Topics: Allergens; Animals; Asthma; Cell Movement; Chronic Disease; Disease Models, Animal; Dust; Inflammation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mites; Respiratory Mucosa; STAT3 Transcription Factor; Th2 Cells | 2007 |
Immunomodulatory effects of oak dust exposure in a murine model of allergic asthma.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Disease Models, Animal; Dust; Female; Inhalation Exposure; Interleukin-13; Leukocytes; Lung; Macrophage Inflammatory Proteins; Macrophages; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Ovalbumin; Quercus; RNA, Messenger; Tumor Necrosis Factor-alpha; Wood | 2007 |
[Pathological study of lung cancer induced by Yunnan tin mine dusts in F344 rats].
Topics: Animals; Disease Models, Animal; Dust; Female; Lung; Lung Neoplasms; Male; Rats; Rats, Inbred F344; Tin | 2007 |
Instillation of coarse ash particulate matter and lipopolysaccharide produces a systemic inflammatory response in mice.
Topics: Animals; Coal; Disease Models, Animal; Dust; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Particulate Matter; Pneumonia; Tumor Necrosis Factor-alpha | 2007 |
Swine dust exposure is a model for rapid induction of non-allergic neutrophil inflammation in the nasal mucosa of healthy volunteers, and the symptoms as well as the microcirculation are modified by nasal lavage.
Topics: Albumins; Animals; Disease Models, Animal; Dust; Humans; Inhalation Exposure; Interleukin-8; Laser-Doppler Flowmetry; Microcirculation; Nasal Lavage Fluid; Nasal Mucosa; Neutrophils; Rhinitis; Swine | 2007 |
The effects of microbial materials adhered to Asian sand dust on allergic lung inflammation.
Topics: Air Microbiology; Air Pollutants; Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Disasters; Disease Models, Animal; Dust; Lung; Male; Mice; Mice, Inbred ICR; Particle Size; Pneumonia; Respiratory Hypersensitivity; Silicon Dioxide | 2008 |
Chlamydophila spp. infection in horses with recurrent airway obstruction: similarities to human chronic obstructive disease.
Topics: Airway Obstruction; Animals; Chlamydophila Infections; Chlamydophila psittaci; Disease Models, Animal; DNA, Bacterial; Dust; Female; Fluorescent Antibody Technique; Horse Diseases; Horses; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Respiratory Mucosa | 2008 |
Pharmacokinetic modeling of manganese in the rat IV: Assessing factors that contribute to brain accumulation during inhalation exposure.
Topics: Administration, Oral; Air Pollutants; Animals; Brain; Brain Chemistry; Disease Models, Animal; Dust; Environmental Exposure; Inhalation Exposure; Liver; Manganese; Models, Biological; Rats; Risk Assessment | 2008 |
Crystalline silica is a negative modifier of pulmonary cytochrome P-4501A1 induction.
Topics: Air Pollutants; Animals; beta-Naphthoflavone; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Disease Models, Animal; Dust; Enzyme Induction; Enzyme Inhibitors; Inhalation Exposure; Male; Occupational Exposure; Particulate Matter; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Silicon Dioxide; Silicosis | 2008 |
[Beta-adrenergic receptor in bronchial asthma. Part 1. Pulmonary beta-adrenergic receptor in experimental konjac asthma of the guinea-pig].
Topics: Allergens; Animals; Asthma; Disease Models, Animal; Dust; Guinea Pigs; In Vitro Techniques; Lung; Male; Mannans; Polysaccharides; Receptors, Adrenergic, beta | 1984 |
A small animal model study of perlite and fir bark dust on guinea pig lungs.
Topics: Aluminum Oxide; Animals; Body Weight; Disease Models, Animal; Drinking; Dust; Eating; Female; Guinea Pigs; Lung; Male; Silicon Dioxide; Wood | 1983 |
Hypersensitivity pneumonitis.
Topics: Adrenal Cortex Hormones; Alveolitis, Extrinsic Allergic; Animals; Antigens; Cromolyn Sodium; Disease Models, Animal; Dust; Humans; Lung; Lymphocyte Activation; Lymphokines; Mice; Occupational Diseases; Precipitins; Rabbits; Rats; Therapeutic Irrigation | 1984 |
Pulmonary reactions to inhaled cotton dust: an animal model for byssinosis.
Topics: Animals; Apnea; Body Weight; Byssinosis; Carbon Dioxide; Cellulose; Cough; Disease Models, Animal; Dust; Gossypium; Guinea Pigs; Male; Particle Size; Plethysmography, Whole Body; Respiration; Respiratory Function Tests; Tidal Volume | 1984 |
Animal studies of potential chronic lung disease of workers in swine confinement buildings.
Topics: Agricultural Workers' Diseases; Alveolitis, Extrinsic Allergic; Animals; Chronic Disease; Disease Models, Animal; Dust; Histiocytes; Housing, Animal; Lung; Lung Diseases; Pneumonia; Precipitins; Swine; Trachea; Turbinates | 1984 |
The pathogenetic role of inhaled microbial material in pulmonary mycotoxicosis as demonstrated in an animal model.
Topics: Animal Feed; Animals; Disease Models, Animal; Dust; Lung Diseases, Fungal; Rabbits; Silage | 1981 |
Pulmonary alveolar phospholipoproteinosis induced by Orasol Navy Blue dust.
Topics: Animals; Azo Compounds; Body Weight; Coloring Agents; Disease Models, Animal; Dust; Guinea Pigs; Macrophages, Alveolar; Male; Mice; Microscopy, Fluorescence; Naphthols; Particle Size; Pulmonary Alveolar Proteinosis; Pulmonary Alveoli; Rats; Reproducibility of Results; Staining and Labeling | 1994 |
An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals.
Topics: Air Pollutants; Animals; Asbestos; Disease Models, Animal; Dust; Evaluation Studies as Topic; Logistic Models; Male; Minerals; Particle Size; Rats; Rats, Inbred F344; Time Factors | 1994 |
A naturally occurring model of immunoglobulin E antibody-mediated hypersensitivity in laboratory animals.
Topics: Aerosols; Allergens; Animals; Disease Models, Animal; Dogs; Dust; Female; Hypersensitivity; Immunization, Passive; Immunoglobulin E; Lung; Macaca mulatta; Male; Mites; Skin Tests | 1994 |
Organic dust exposure from compost handling: response of an animal model.
Topics: Agriculture; Animals; Disease Models, Animal; Dust; Guinea Pigs; Respiratory Tract Diseases; Wood | 1993 |
A model of immune-mediated lung disease in rats sensitized to house dust mite and upregulation of immunity following exposure to nitrogen dioxide.
Topics: Animals; Disease Models, Animal; Dust; Lung Diseases; Nitrogen Dioxide; Rats; Rats, Inbred BN; Up-Regulation | 1996 |
Pharmacologic characterization of wool dust extract in isolated guinea pig trachea.
Topics: Air Pollutants, Occupational; Animals; Atropine; Bronchoconstriction; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Dust; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Indomethacin; Leukotriene Antagonists; Male; Occupational Exposure; Pyrilamine; Trachea; Verapamil; Wool | 1995 |
House dust mite-induced sensitivity in mice.
Topics: Allergens; Amino Acid Sequence; Animals; Base Sequence; Disease Models, Animal; DNA Primers; Dust; Hybridomas; Hypersensitivity; Immunization; Immunoglobulin E; In Vitro Techniques; Lung; Lymphocyte Activation; Mice; Mites; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets; Trachea | 1998 |
Silicosis in mice: effects of dose, time, and genetic strain.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Dust; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred MRL lpr; Mice, Inbred NZB; Mice, Inbred Strains; Silicic Acid; Silicosis | 1998 |
Comparison of sensitization to crude and purified house dust mite allergens in inbred mice.
Topics: Aerosols; Allergens; Anaphylaxis; Animals; Bronchitis; Bronchoalveolar Lavage; Bronchoconstriction; Disease Models, Animal; Dust; Hypersensitivity; Immunoglobulin E; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mites | 1998 |
The possibility of testing antiparasitical substances using the cockroach as a model.
Topics: Animals; Antiparasitic Agents; Cockroaches; Disease Models, Animal; Dust; Mites; Phthiraptera | 1999 |
[Pulmonary surfactant status in experimental dust-induced bronchitis based on the data from dynamic interphase tensiometry].
Topics: Animals; Bronchitis; Chronic Disease; Disease Models, Animal; Dust; Lipid Peroxidation; Lung; Male; Pulmonary Surfactants; Rats; Rats, Wistar; Silicon Dioxide; Surface Tension; Temperature | 1999 |
Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness.
Topics: Allergens; Animals; Antibody Specificity; Antigens, Dermatophagoides; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Immunologic; Dust; Eosinophilia; Eosinophils; Glycoproteins; Immunoglobulin E; Lung; Male; Mice; Mice, Inbred C57BL; Mites | 2000 |
Isolation of dust mites from houses of Egyptian allergic patients and induction of experimental sensitivity by Dermatophagoides pteronyssinus.
Topics: Animals; Disease Models, Animal; Dust; Egypt; Humans; Hypersensitivity; Immunoglobulin E; Interleukin-4; Mice; Mites | 2000 |
Pulmonary response of mice to aqueous cotton dust extract.
Topics: Animals; Bronchoalveolar Lavage Fluid; Byssinosis; Disease Models, Animal; Disease Progression; Dust; Environmental Exposure; Gossypium; Lymphocyte Count; Macrophages; Mice; Mice, Inbred BALB C; Proteins; Random Allocation; Time Factors | 2000 |
Endotoxin responsiveness and subchronic grain dust-induced airway disease.
Topics: Actins; Acute Disease; Administration, Inhalation; Aerosols; Airway Resistance; Animals; Bronchoalveolar Lavage Fluid; Collagen; Crosses, Genetic; Disease Models, Animal; Dust; Endotoxins; Genetic Predisposition to Disease; Immunohistochemistry; Lung Diseases, Obstructive; Methacholine Chloride; Mice; Mice, Inbred C3H; Neutrophils; Pneumonia; Species Specificity; Zea mays | 2001 |
In vivo experimental model for silicosis.
Topics: Animals; Disease Models, Animal; Dust; Inhalation Exposure; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar; Silicon Dioxide; Silicosis; Trachea | 2000 |
[Biological effects of chrysotile asbestos dust obtained by dry and moist enriching methods (experimental study)].
Topics: Animals; Asbestos, Serpentine; Disease Models, Animal; Dust; Female; Pulmonary Fibrosis; Rats | 2000 |
Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization.
Topics: Allergens; Animals; Antibodies, Monoclonal; Antigens, Dermatophagoides; Asthma; Disease Models, Animal; Dust; Female; Glycoproteins; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Lung; Mice; Mice, Inbred C57BL; Mites; Mucous Membrane; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2001 |
[Silicosis hazard of silica dusts in diamond mining industry (experimental study)].
Topics: Animals; Diamond; Disease Models, Animal; Dust; Hazardous Substances; Humans; Industry; Male; Mining; Occupational Diseases; Rats; Silicon Dioxide; Silicosis | 2001 |
Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens.
Topics: Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokines, CC; Chemotactic Factors, Eosinophil; Child; Cockroaches; Cytokines; Disease Models, Animal; Dust; Eosinophilia; Female; Humans; Mice; Mice, Inbred BALB C | 2001 |
Effect of cirrhosis on pulmonary fibrogenesis caused by silica dust in rats.
Topics: Animals; Disease Models, Animal; Dust; Liver Cirrhosis; Male; Pulmonary Fibrosis; Rats; Silicon Dioxide; Silicosis | 1975 |
Early biochemical response of pulmonary tissue to manganese dioxide.
Topics: Animals; Disease Models, Animal; Dust; Lung; Male; Manganese; Pneumoconiosis; Proteins; Rats; Tissue Distribution | 1977 |
Influence of cotton dust inhalation on free lung cells in rats and guinea pigs.
Topics: Age Factors; Animals; Byssinosis; Disease Models, Animal; Dust; Erythrocyte Count; Female; Gossypium; Guinea Pigs; Leukocyte Count; Lung; Male; Neutrophils; Rats; Sex Factors; Species Specificity; Time Factors | 1975 |
Fibrogenic response in murine lungs to asbestos.
Topics: Acute Disease; Animals; Asbestos; Asbestosis; Disease Models, Animal; Dust; India; Lung; Mice; Pulmonary Fibrosis | 1975 |
[Development of pulmonary fibrosis in the animal experiment after repeated intratracheal coal-dust administration in relation to total dust intake].
Topics: Animals; Coal; Disease Models, Animal; Dust; Female; Pulmonary Fibrosis; Rats; Time Factors; Trachea | 1975 |
Lack of late-phase airway responses in conscious guinea pigs after a variety of antigen challenges.
Topics: Aerosols; Allergens; Animals; Antigens; Ascaris; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dust; Eosinophils; Guinea Pigs; Leukocyte Count; Male; Ovalbumin; Respiratory Mechanics | 1992 |
[Comparative analysis of biological aggressiveness of dusts from different coal mines for determining the risk of development of pneumoconiosis among miners].
Topics: Air Pollutants, Occupational; Animals; Anthracosilicosis; Coal Mining; Disease Models, Animal; Dust; Humans; Hydroxyproline; Lung; Poland; Rats; Rats, Inbred Strains; Risk Factors; Silicon Dioxide | 1992 |
On the alteration of pulmonary arteries in different experimental pneumoconioses.
Topics: Acetylcholine; Animals; Blood Gas Analysis; Disease Models, Animal; Dust; Injections, Intra-Arterial; Male; Norepinephrine; Paraffin Embedding; Pneumoconiosis; Polyvinyl Chloride; Pulmonary Artery; Rats; Respiration | 1992 |
[Biological testing of the fibrogenic effect of dust from the "Sosnowiec" mine on the lung tissue].
Topics: Air Pollutants, Occupational; Animals; Anthracosilicosis; Coal Mining; Disease Models, Animal; Dust; Lung; Male; Poland; Pulmonary Fibrosis; Rats; Rats, Wistar | 1992 |
[Comparative evaluation of the effects of detergents Emulkop and Rokafenol N-8 on the aggressiveness of coal mine dust in the aspect of prevention of its biological effect].
Topics: Air Pollutants, Occupational; Air Pollution; Animals; Anthracosilicosis; Coal Mining; Detergents; Disease Models, Animal; Dust; Female; Male; Models, Biological; Poland; Rabbits; Rats; Rats, Wistar | 1992 |
[The modelling of the extrinsic allergic alveolitis of woodworkers].
Topics: Air Pollutants, Occupational; Alveolitis, Extrinsic Allergic; Animals; Disease Models, Animal; Dust; Freund's Adjuvant; Humans; Lung; Male; Occupational Diseases; Rats; Solvents; Time Factors; Wood | 1992 |
Bronchial hyperreactivity after inhalation of trimellitic anhydride dust in guinea pigs after intradermal sensitization to the free hapten.
Topics: Air Pollutants; Airway Resistance; Animals; Antibodies; Biopsy; Bronchial Hyperreactivity; Disease Models, Animal; Dust; Enzyme-Linked Immunosorbent Assay; Eosinophils; Evaluation Studies as Topic; Guinea Pigs; Immunization; Immunoglobulin G; Male; Photomicrography; Phthalic Anhydrides | 1992 |
[Evaluation of the fibrogenic effect of coke dust on the lungs and internal organs of experimental animals].
Topics: Air Pollutants; Animals; Chemical Industry; Coke; Disease Models, Animal; Dust; Ferric Compounds; Hydroxyproline; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Inbred Strains; Silicon Dioxide; Silicosis | 1991 |
[Biological attestation of the fibrogenic effect of dust from selected coal mines on the lung tissue].
Topics: Air Pollutants, Occupational; Animals; Anthracosilicosis; Coal Mining; Disease Models, Animal; Dust; Hydroxyproline; Lung; Male; Poland; Pulmonary Fibrosis; Rats; Rats, Inbred Strains; Silicon Dioxide | 1991 |
[Evaluation of the effect of the detergent Rokafenol N-8 on the development and course of experimental pneumoconiosis caused by coal mine dust].
Topics: Administration, Inhalation; Animals; Anthracosilicosis; Coal; Coal Mining; Detergents; Disease Models, Animal; Dust; Hydroxyproline; Lung; Rats; Stimulation, Chemical | 1991 |
[Biological effect of brown coal dust in experimental studies].
Topics: Air Pollutants; Animals; Coal; Disease Models, Animal; Dust; Female; Pulmonary Fibrosis; Rats; Silicon Dioxide; Silicosis | 1990 |
[Evaluation of general toxicity of detergent Rokafenol-8 and its effect on the aggressiveness of coal mine dust].
Topics: Animals; Chemical and Drug Induced Liver Injury; Coal Mining; Detergents; Disease Models, Animal; Drug Synergism; Dust; Hepatitis, Animal; Liver; Nonoxynol; Polyethylene Glycols; Rabbits; Rats; Silicon Dioxide | 1990 |
[Biological testing of fibrogenic effect of dust from the "Gliwice" mine on the lung tissue].
Topics: Air Pollutants, Occupational; Animals; Anthracosilicosis; Coal Mining; Disease Models, Animal; Dust; Lung; Male; Occupational Diseases; Pulmonary Fibrosis; Rats; Rats, Inbred Strains | 1990 |
Inflammation in the lungs of rats after deposition of dust collected from the air of wool mills: the role of epithelial injury and complement activation.
Topics: Animals; Bronchitis; Bronchoalveolar Lavage Fluid; Cell Count; Chemotaxis; Complement Activation; Disease Models, Animal; Dust; Epithelium; Macrophages; Neutrophils; Occupational Diseases; Rats; Rats, Inbred Strains; Textile Industry; Wool | 1990 |
Dogs hypersensitive to house dust mite.
Topics: Animals; Disease Models, Animal; Dogs; Dust; Female; Hypersensitivity; Male; Mites | 1989 |
The use of experimental airborne infections to monitor impairments in pulmonary defenses.
Topics: Air Microbiology; Air Pollutants; Animals; Cadmium; Cell Survival; Disease Models, Animal; Disease Susceptibility; Dust; Guinea Pigs; Lung; Lung Diseases; Manganese Poisoning; Nickel; Rats; Streptococcal Infections; Streptococcus pyogenes | 1988 |
Animal model of grain worker's lung.
Topics: Animals; Disease Models, Animal; Dust; Edible Grain; Humans; Pulmonary Fibrosis; Rabbits; Respiratory Tract Diseases | 1986 |
[Simulation of the conditions for the occurrence of pneumoconiosis in an experiment].
Topics: Animals; Atmosphere Exposure Chambers; Disease Models, Animal; Dust; Equipment Design; Pneumoconiosis | 1986 |
[Models of experimental pneumoconiosis and dust-induced bronchitis via inhalational exposure to dust].
Topics: Animals; Bronchitis; Disease Models, Animal; Dust; Environmental Exposure; Lung; Methods; Particle Size; Pneumoconiosis; Radiography; Rats; Time Factors | 1986 |
Pathology of mice intranasally inoculated with uranium- and zirconium-containing rock dust from Kvanefjeld, Greenland.
Topics: Animals; Disease Models, Animal; Dust; Female; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C57BL; Uranium; Zirconium | 1986 |
Histomorphometric study of the pulmonary response of guinea pigs to chronic cotton dust inhalation.
Topics: Animals; Bronchi; Byssinosis; Disease Models, Animal; Dust; Gossypium; Guinea Pigs; Lung; Pulmonary Alveoli | 1986 |
Haemodynamics in animals.
Topics: Animals; Anthracosilicosis; Blood Pressure; Disease Models, Animal; Dust; Environmental Exposure; Haplorhini; Heart; Heart Rate; Lung; Macaca mulatta; Organ Size; Rats; Respiratory Function Tests | 1974 |
Experimental model systems of pneumoconiosis. I. The effect of dusts on subcutaneous sponge implants in the rat.
Topics: Animals; Collagen; Disease Models, Animal; Dust; Male; Minerals; Pneumoconiosis; Pulmonary Fibrosis; Rats; Silicon Dioxide | 1968 |
[Animal experimental studies in the lung on the problem of retention and elimination of calcium fluoride. (Pneumoconiosis of fluorspar-workers)].
Topics: Acute Disease; Animals; Calcium Fluoride; Disease Models, Animal; Dust; Female; Inflammation; Lung Diseases; Lymphadenitis; Occupational Medicine; Pneumoconiosis; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Silicon Dioxide | 1970 |
[Characteristics in the development of pneumoconiosis during the exposure to grain dust].
Topics: Animals; Bronchiectasis; Bronchitis; Disease Models, Animal; Dust; Edible Grain; Lung; Methods; Pneumoconiosis; Pulmonary Emphysema; Rats; Silicon Dioxide; Time Factors | 1971 |
Lung function studies in experimental silicosis with a radiospirometric technique and some observations on a technique for inducing unilateral silicosis. A preliminary report.
Topics: Animals; Catheterization; Collagen; Disease Models, Animal; Dust; Lung; Methods; Organ Size; Perfusion; Rabbits; Radiography; Radioisotopes; Silicon Dioxide; Silicosis; Spirometry; Time Factors; Xenon | 1970 |
[Induction of Mycobacterium infection by introduction of the organisms into the lung through an intratracheal vinyl tube].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Dust; Ethambutol; Guinea Pigs; Intubation, Intratracheal; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Silicon Dioxide; Tuberculosis, Pulmonary | 1972 |
Acute bronchitis due to cotton plant polyphenols.
Topics: Aerosols; Animals; Basement Membrane; Biological Assay; Bronchi; Bronchitis; Cell Movement; Cricetinae; Disease Models, Animal; Dust; Flavonoids; Gossypium; Guinea Pigs; Leukocytes; Microscopy, Electron; Phagocytosis; Phenols; Plant Extracts; Trachea | 1974 |
Leukocyte recruitment through airway walls by condensed vegetable tannins and quercetin.
Topics: Aerosols; Animals; Basement Membrane; Byssinosis; Cricetinae; Disease Models, Animal; Dust; Epithelial Cells; Epithelium; Flavonoids; Gossypium; Histological Techniques; Leukocytes; Lung; Microscopy, Electron; Pneumoconiosis; Pulmonary Alveoli; Tannins; Time Factors | 1973 |
Effect of mica dust on the lungs of rats.
Topics: Animals; Bronchopneumonia; Disease Models, Animal; Dust; Histological Techniques; Lung; Male; Microscopy, Polarization; Rats; Silicosis; Time Factors | 1973 |
[Fibrinogenic nature of inhaled fluxed sinter cake dust].
Topics: Aluminum; Animals; Calcium; Disease Models, Animal; Dust; Iron; Male; Occupational Medicine; Pneumoconiosis; Rats; Silicon | 1972 |
The effects of inhaled crocidolites from Transvaal and North-west Cape mines on the lungs of rats and guinea-pigs.
Topics: Animals; Asbestos; Asbestosis; Bronchi; Collagen; Disease Models, Animal; Dust; Guinea Pigs; Lung; Lung Neoplasms; Male; Mesothelioma; Microscopy, Electron; Rats; South Africa | 1972 |
[Device for modeling pneumoconioses with dynamic loading of experimental animals].
Topics: Aerosols; Animals; Disease Models, Animal; Dust; Equipment and Supplies; Physical Exertion; Pneumoconiosis; Rats | 1974 |
Emphysema and pneumoconiosis. An experimental study on their interrelationship.
Topics: Animals; Coal; Cricetinae; Disease Models, Animal; Dust; Emphysema; Guinea Pigs; Papain; Pneumoconiosis; Quartz; Rats | 1969 |
[Morphology and pathogenesis of chronic bronchitis due to grain dust (experimental study)].
Topics: Animals; Bronchi; Bronchial Diseases; Bronchiectasis; Bronchitis; Chronic Disease; Disease Models, Animal; Dust; Edible Grain; Granuloma; Humans; Lung; Methods; Pneumoconiosis; Rats; Time Factors | 1972 |
[Effect of grain dust ash residue on the respiratory organs of animals].
Topics: Animals; Disease Models, Animal; Dust; Edible Grain; Pneumoconiosis; Rats | 1972 |
Experimental farmer's lung in guinea-pigs.
Topics: Actinomycetales; Animals; Bronchi; Disease Models, Animal; Dust; Farmer's Lung; Guinea Pigs; Inflammation; Lung; Poaceae; Pulmonary Alveoli | 1971 |
[Influence of inhaled dust in iron processing on the interstitial muscles of the isolated frog lung].
Topics: Animals; Anura; Disease Models, Animal; Dust; Electric Stimulation; Iron; Muscle, Smooth; Pulmonary Alveoli; Respiration | 1970 |
[Effect of aerosol administered poly-2-vinylpyridin-N-oxid(PVPNO) on the cellular pulmonary clearance].
Topics: Aerosols; Animals; Cyclic N-Oxides; Disease Models, Animal; Dust; Macrophages; Metabolic Clearance Rate; Occupational Medicine; Phagocytosis; Polyvinyls; Pulmonary Alveoli; Pyridines; Rats; Silicosis; Time Factors | 1970 |
Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Locomotion; Male; Mice; Motor Activity; Nicotine; Phencyclidine; Recognition, Psychology; Schizophrenia; Sensory Gating | 2021 |
Neonatal NMDA blockade alters the LTP, LTD and cognitive functions in male and female Wistar rats.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; CA1 Region, Hippocampal; Cognitive Dysfunction; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Hippocampus; Learning; Male; Neuronal Plasticity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar | 2022 |
Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder.
Topics: Animals; Disease Models, Animal; Guanylate Kinases; Haploinsufficiency; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Phencyclidine; Rats; Schizophrenia; Social Behavior; Tumor Suppressor Proteins | 2022 |
Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats.
Topics: Animals; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Excitatory Amino Acid Antagonists; Female; Hippocampus; Phencyclidine; Prefrontal Cortex; Rats; Receptors, N-Methyl-D-Aspartate | 2022 |
Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Akathisia, Drug-Induced; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Male; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 2022 |
Targeting α6GABA
Topics: Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Humans; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, GABA-A; Schizophrenia | 2022 |
Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia.
Topics: Animals; Connective Tissue Growth Factor; Disease Models, Animal; Hallucinogens; Mice; Neurons; Phencyclidine; Proto-Oncogene Proteins c-fos; Purkinje Cells; Receptors, Phencyclidine; Schizophrenia; Synapses | 2022 |
5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Guanidines; Isoquinolines; Male; Memory Disorders; Methamphetamine; Mice; Mice, Knockout; Phencyclidine; Rats; Rats, Transgenic; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Antagonists | 2022 |
Fingolimod ameliorates schizophrenia-like cognitive impairments induced by phencyclidine in male rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2023 |
Handling prevents and reverses cognitive deficits induced by sub-chronic phencyclidine in a model for schizophrenia in rats.
Topics: Animals; Cognition; Cognition Disorders; Cognitive Dysfunction; Disease Models, Animal; Female; Phencyclidine; Rats; Schizophrenia | 2023 |
Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Olanzapine; Phencyclidine; Schizophrenia | 2023 |
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice.
Topics: Animals; Disease Models, Animal; Female; Male; Mice; Nicotine; Phencyclidine; Prefrontal Cortex; Schizophrenia; Synaptic Transmission | 2023 |
Increased translocator protein (TSPO) binding throughout neurodevelopment in the perinatal phencyclidine rodent model of schizophrenia.
Topics: Animals; Brain; Carrier Proteins; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Phencyclidine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Schizophrenia | 2019 |
Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia.
Topics: Animals; Behavior, Animal; Conditioning, Eyelid; Deep Brain Stimulation; Disease Models, Animal; Hallucinogens; Hippocampus; Learning Disabilities; Male; Neurons; Optogenetics; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2019 |
Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model.
Topics: Animals; Arachidonic Acids; Disease Models, Animal; Dronabinol; Endocannabinoids; Glycogen Synthase Kinase 3 beta; Male; Motor Activity; Neurons; Phencyclidine; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Schizophrenia; Signal Transduction; Ventral Tegmental Area | 2020 |
Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Female; Longitudinal Studies; Memory Disorders; Phencyclidine; Physical Conditioning, Animal; Rats; Recognition, Psychology; Running; Schizophrenia | 2020 |
Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system - implications for the 3Rs and preclinical drug discovery.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dissociative Disorders; Locomotion; Male; Phencyclidine; Radio Frequency Identification Device; Rats; Reproducibility of Results; Social Behavior; Time Factors | 2020 |
Calbindin Deficits May Underlie Dissociable Effects of 5-HT
Topics: Animals; Behavior, Animal; Calbindins; Cognition; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Phencyclidine; Receptors, Metabotropic Glutamate; Receptors, Serotonin; Schizophrenia; Serotonin | 2020 |
Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia.
Topics: Animals; Disease Models, Animal; Extracellular Vesicles; Humans; Mesenchymal Stem Cells; Mice; Phencyclidine; Prefrontal Cortex; Schizophrenia | 2020 |
Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cells, Cultured; Dependency, Psychological; Disease Models, Animal; Female; Humans; Male; Mice; Middle Aged; Nicotine; Nucleus Accumbens; Phencyclidine; Schizophrenia; Social Interaction | 2020 |
Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Executive Function; Locomotion; Male; Phencyclidine; Prepulse Inhibition; Rats; Rats, Wistar; Recognition, Psychology; Reversal Learning; Schizophrenia; Schizophrenic Psychology; Social Isolation | 2021 |
Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Phencyclidine; Phosphorylation; Physical Conditioning, Animal; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology | 2021 |
Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia.
Topics: Animals; Conditioning, Operant; Cyclic Nucleotide Phosphodiesterases, Type 1; Disease Models, Animal; Female; Goals; Hallucinogens; Phencyclidine; Phosphodiesterase Inhibitors; Prefrontal Cortex; Rats; Schizophrenia | 2021 |
Depolarizing GABA
Topics: Animals; Bumetanide; Cognitive Dysfunction; Disease Models, Animal; gamma-Aminobutyric Acid; Mice; Phencyclidine; Prefrontal Cortex; Schizophrenia | 2021 |
Multiple nicotinic acetylcholine receptor subtypes regulate social or cognitive behaviors in mice repeatedly administered phencyclidine.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Mice; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Receptors, Nicotinic; Schizophrenia; Smoking; Social Behavior | 2021 |
Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Phencyclidine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Signal Transduction | 2021 |
Andrographolide improves PCP-induced schizophrenia-like behaviors through blocking interaction between NRF2 and KEAP1.
Topics: Andrographis paniculata; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Diterpenes; Epistasis, Genetic; Inflammation; Kelch-Like ECH-Associated Protein 1; Male; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Phencyclidine; Phytotherapy; Schizophrenia; Signal Transduction | 2021 |
Acquisition of nicotine self-administration in amphetamine and phencyclidine models of schizophrenia: A role for stress?
Topics: Amphetamine; Animals; Disease Models, Animal; Learning; Male; Motor Activity; Nicotine; Nicotinic Agonists; Phencyclidine; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Self Administration; Stress, Psychological; Tobacco Use Disorder | 2018 |
Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat.
Topics: Animals; Brain; Brain Mapping; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hallucinogens; Image Processing, Computer-Assisted; Interpersonal Relations; Locomotion; Magnetic Resonance Imaging; Male; Microdialysis; Oxygen; Phencyclidine; Rats; Rats, Wistar; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2017 |
Generation of the Acute Phencyclidine Rat Model for Proteomic Studies of Schizophrenia.
Topics: Acute Disease; Animals; Brain Chemistry; Disease Models, Animal; Hormones; Immunoassay; Inflammation; Locomotion; Male; Nerve Tissue Proteins; Phencyclidine; Proteomics; Rats; Rats, Sprague-Dawley; Schizophrenia; Serum | 2017 |
RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Memory; Mice, Inbred C57BL; Motor Activity; Neurotransmitter Agents; Phencyclidine; Psychotic Disorders; Random Allocation; Reversal Learning; Schizophrenia; Schizophrenic Psychology | 2017 |
Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
Topics: Animals; Behavior, Animal; Cognition; Cognitive Dysfunction; Disease Models, Animal; Dopamine; Female; Phencyclidine; Prefrontal Cortex; Rats; Recognition, Psychology; Schizophrenia | 2017 |
Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.
Topics: Animals; Animals, Newborn; Cortical Synchronization; Disease Models, Animal; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino Acid Antagonists; Gamma Rhythm; Hippocampus; Male; Neural Pathways; Phencyclidine; Prefrontal Cortex; Random Allocation; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Theta Rhythm | 2017 |
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.
Topics: Acrylamides; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Furans; Galantamine; Male; Phencyclidine; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors | 2017 |
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Cannabinoids; Carbamates; Disease Models, Animal; Exploratory Behavior; Interpersonal Relations; Male; Phencyclidine; Piperidines; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2017 |
ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers.
Topics: Animals; Animals, Outbred Strains; Antipsychotic Agents; Clozapine; Disease Models, Animal; ErbB Receptors; Male; Metabolic Syndrome; Mice, Inbred ICR; Morpholines; Phencyclidine; Protein Kinase Inhibitors; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Signal Transduction | 2018 |
Phencyclidine-like in vivo effects of methoxetamine in mice and rats.
Topics: Animals; Body Temperature; Cyclohexanones; Cyclohexylamines; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Illicit Drugs; Locomotion; Male; Mice; Phencyclidine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Telemetry | 2018 |
Phencyclidine-induced dysregulation of primary cilia in the rodent brain.
Topics: Animals; beta Catenin; Brain; CA1 Region, Hippocampal; Cerebral Cortex; Cilia; Cognition; Disease Models, Animal; Dopamine; Dopamine Agonists; Hippocampus; Male; Mice; Mice, Inbred C57BL; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2017 |
Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats.
Topics: Acoustic Stimulation; Amphetamine; Analgesics; Animals; Antidepressive Agents; Association Learning; Central Nervous System Stimulants; Cocaine; Conditioning, Classical; Decision Making; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Ketamine; Male; Models, Biological; Phencyclidine; Rats; Reaction Time; Time Factors | 2017 |
Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Down-Regulation; Ginkgolides; Hippocampus; Lactones; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Phencyclidine; Platelet Membrane Glycoproteins; Prefrontal Cortex; Psychoses, Substance-Induced; Pyrrolidines; Receptors, G-Protein-Coupled; RNA, Messenger; Thiocarbamates | 2018 |
Phencyclidine increased while isolation rearing did not affect progressive ratio responding in rats: Investigating potential models of amotivation in schizophrenia.
Topics: Affect; Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Motivation; N-Methylaspartate; Phencyclidine; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Reward; Schizophrenia; Social Isolation | 2019 |
A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.
Topics: Abnormalities, Multiple; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Chromosome Deletion; Chromosomes, Human, Pair 1; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Excitatory Amino Acid Antagonists; Megalencephaly; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Phencyclidine; Phenotype; Prepulse Inhibition; Quinpirole; Receptors, Dopamine; Schizophrenia; Ventral Tegmental Area | 2017 |
Downregulation of 5-hydroxytryptamine
Topics: Animals; Attention; Central Nervous System Stimulants; Cognition; Disease Models, Animal; Down-Regulation; Executive Function; Gene Knockdown Techniques; Impulsive Behavior; Male; Maze Learning; Memory; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Phencyclidine; Prefrontal Cortex; Random Allocation; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology | 2018 |
Male rats treated with subchronic PCP show intact olfaction and enhanced interest for a social odour in the olfactory habituation/dishabituation test.
Topics: Animals; Discrimination, Psychological; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Habituation, Psychophysiologic; Male; Motivation; Olfactory Perception; Pattern Recognition, Physiological; Phencyclidine; Psychological Tests; Random Allocation; Rats, Sprague-Dawley; Schizophrenia; Social Behavior; Time Factors | 2018 |
Schizophrenia-like olfactory dysfunction induced by acute and postnatal phencyclidine exposure in rats.
Topics: Animals; Antipsychotic Agents; Brain; Disease Models, Animal; Female; Male; Neurons; Olanzapine; Olfactory Bulb; Olfactory Perception; Perceptual Disorders; Phencyclidine; Rats, Sprague-Dawley; Schizophrenia; Sex Factors | 2018 |
Estradiol and luteinizing hormone regulate recognition memory following subchronic phencyclidine: Evidence for hippocampal GABA action.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Estradiol; Female; Glutamate Decarboxylase; Hippocampus; Luteinizing Hormone; Memory; Memory Disorders; Memory, Short-Term; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Recognition, Psychology; Schizophrenia | 2018 |
Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor acti
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Locomotion; Male; Microdialysis; Norepinephrine; Phencyclidine; Piperazines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2018 |
Phencyclidine and Scopolamine for Modeling Amnesia in Rodents: Direct Comparison with the Use of Barnes Maze Test and Contextual Fear Conditioning Test in Mice.
Topics: Amnesia; Analysis of Variance; Animals; Cholinergic Antagonists; Conditioning, Psychological; Disease Models, Animal; Fear; Hallucinogens; Locomotion; Male; Maze Learning; Mice; Mice, Inbred C57BL; Phencyclidine; Reaction Time; Scopolamine | 2018 |
Phencyclidine dose optimisation for induction of spatial learning and memory deficits related to schizophrenia in C57BL/6 mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Memory Disorders; Mice, Inbred C57BL; Phencyclidine; Schizophrenic Psychology; Spatial Learning; Spatial Memory | 2018 |
Bacopa monnieri (Brahmi) Prevents Cognitive Deficit by Maintaining CA2/3 VGLUT1 Density of Sub-Chronic Phencyclidine Rat Model of Schizophrenia in Normal Level.
Topics: Animals; Bacopa; Behavior, Animal; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Neostriatum; Neuroprotective Agents; Nootropic Agents; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar; Schizophrenia; Vesicular Glutamate Transport Protein 1 | 2016 |
Clozapine attenuates mitochondrial burdens and abnormal behaviors elicited by phencyclidine in mice via inhibition of p47
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Chromones; Clozapine; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Morpholines; NADPH Oxidases; Oxidative Stress; Phencyclidine; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Schizophrenia; Signal Transduction | 2018 |
The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Donepezil; Excitatory Amino Acid Antagonists; Male; Maze Learning; Mice; Mice, Inbred ICR; Nootropic Agents; Phencyclidine; Schizophrenia | 2018 |
Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hallucinogens; Locomotion; Male; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Behavior; Synapsins | 2019 |
Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Phencyclidine; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Structure-Activity Relationship | 2019 |
Disruption of latent inhibition by subchronic phencyclidine pretreatment in rats.
Topics: Animals; Behavior, Animal; Cognition; Conditioning, Operant; Disease Models, Animal; Female; Memory; Motor Activity; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2019 |
Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.
Topics: Animals; Cognition; Disease Models, Animal; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Gene Expression Regulation; Haplorhini; Male; Maze Learning; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, AMPA; Schizophrenia; Thiadiazines | 2019 |
Functional roles of the glial glutamate transporter (GLAST) in emotional and cognitive abnormalities of mice after repeated phencyclidine administration.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Emotions; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 1; Female; Male; Mice, Inbred C57BL; Mice, Transgenic; Neuroglia; Phencyclidine; Prefrontal Cortex; Schizophrenia | 2019 |
Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
Topics: AIDS-Related Complex; Amphetamines; Analysis of Variance; Animals; Autoradiography; Disease Models, Animal; Gene Expression Regulation; Genes, Immediate-Early; Male; Mice; Mice, Inbred C57BL; Phencyclidine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Receptors, Serotonin, 5-HT2; RNA, Messenger; Schizophrenia; Serotonin Receptor Agonists; Signal Transduction; Time Factors | 2013 |
An investigation of hypofrontality in an animal model of schizophrenia using real-time microelectrochemical sensors for glucose, oxygen, and nitric oxide.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Electrochemical Techniques; Glucose; Hallucinogens; Male; Nitric Oxide; Oxygen; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar; Schizophrenia | 2013 |
NMDA receptor antagonists distort visual grouping in rats performing a modified two-choice visual discrimination task.
Topics: Animals; Choice Behavior; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Impulsive Behavior; Ketamine; Male; Memory; Phencyclidine; Psychometrics; Psychotic Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Visual Perception | 2013 |
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.
Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors | 2013 |
Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia?
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Ultrasonics; Vocalization, Animal | 2013 |
Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
Topics: Animals; Bacopa; Cognition; Cognition Disorders; Disease Models, Animal; Hallucinogens; Hippocampus; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Nootropic Agents; Phencyclidine; Phytotherapy; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2013 |
A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.
Topics: Animals; Brain; Disease Models, Animal; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Mass Spectrometry; Metabolomics; Phencyclidine; Proteomics; Rats; Rats, Sprague-Dawley; Schizophrenia | 2013 |
Expression of presynaptic markers in a neurodevelopmental animal model with relevance to schizophrenia.
Topics: Animals; Animals, Newborn; Biomarkers; Brain; Disease Models, Animal; Enzyme Inhibitors; In Situ Hybridization; Male; Phencyclidine; Rats; Schizophrenia; Synaptophysin; Synaptosomal-Associated Protein 25 | 2013 |
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
Topics: Age Factors; Animals; Animals, Newborn; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Motor Activity; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Stereotyped Behavior; Synaptic Transmission | 2014 |
Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Conditioning, Psychological; Disease Models, Animal; Emotions; Excitatory Amino Acid Antagonists; Freezing Reaction, Cataleptic; Male; Memory; Motor Activity; Neuropsychological Tests; Pattern Recognition, Visual; Phencyclidine; Prepulse Inhibition; Rats; Schizophrenia; Social Isolation | 2014 |
Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity.
Topics: Amino Acids; Animals; Animals, Newborn; Brain; Bridged Bicyclo Compounds, Heterocyclic; Conditioning, Psychological; Disease Models, Animal; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fear; Female; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Neurons; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2014 |
Acute phencyclidine treatment induces extensive and distinct protein phosphorylation in rat frontal cortex.
Topics: Amino Acid Sequence; Animals; Calcium; Disease Models, Animal; Energy Metabolism; Hallucinogens; Homeostasis; Humans; Male; Molecular Sequence Data; Nerve Tissue Proteins; Phencyclidine; Phosphopeptides; Phosphorylation; Prefrontal Cortex; Protein Processing, Post-Translational; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission | 2014 |
The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Memory Disorders; Motor Activity; Phencyclidine; Rats; Recognition, Psychology; Time Factors | 2014 |
A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment.
Topics: Amphetamine; Animals; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Ketamine; Male; Paired-Associate Learning; Phencyclidine; Psychomotor Performance; Random Allocation; Rats; Reaction Time; Scopolamine; Touch | 2014 |
Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
Topics: Age Factors; Animals; Autoradiography; Behavioral Symptoms; Brain; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hallucinogens; Interpersonal Relations; Male; Motor Activity; Phencyclidine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Tritium | 2014 |
PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Phencyclidine; Quinuclidines; Rotarod Performance Test; Schizophrenia; Schizophrenic Psychology; Social Behavior; Thiophenes | 2014 |
Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat.
Topics: Animals; Choice Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hallucinogens; Male; Phencyclidine; Rats; Schizophrenic Psychology; Social Behavior | 2014 |
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Gene Knockdown Techniques; Gene Silencing; Male; MicroRNAs; Motor Activity; Nucleus Accumbens; Phencyclidine; Random Allocation; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Schizophrenia; Social Behavior | 2015 |
Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia.
Topics: Animals; Cognition; Conditioning, Operant; Disease Models, Animal; Male; Phencyclidine; Rats; Reversal Learning; Schizophrenia; Schizophrenic Psychology | 2014 |
Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Haloperidol; Isoindoles; Memory Disorders; Phencyclidine; Piperazines; Piperidines; Pyrimidines; Random Allocation; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Urea | 2015 |
Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Topics: Age Factors; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Chlorocebus aethiops; Cognition; Disease Models, Animal; Disease Susceptibility; Dopamine; Female; Male; Memory, Short-Term; Phencyclidine; Prefrontal Cortex; Schizophrenia; Schizophrenic Psychology; Sex Factors; Spinal Cord; Synapses; Time Factors | 2014 |
Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
Topics: Animals; Basal Forebrain; Benzamides; Carbamates; Central Nervous System Agents; Disease Models, Animal; Dopaminergic Neurons; Endocannabinoids; Hippocampus; Male; Microelectrodes; Phencyclidine; Rats, Sprague-Dawley; Schizophrenia; Sodium Channel Blockers; Tetrodotoxin; Ventral Tegmental Area | 2014 |
Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Exploratory Behavior; Gastrointestinal Tract; Hallucinogens; Male; Microbiota; Motor Activity; Phencyclidine; Rats; Recognition, Psychology; Schizophrenia | 2015 |
Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.
Topics: Animals; Attention; Auditory Perception; Brain; Disease Models, Animal; Gray Matter; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Phencyclidine; Prepulse Inhibition; Rats; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Visual Perception | 2014 |
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
Topics: Adult; Animals; Behavior, Animal; Brain; Case-Control Studies; D-Aspartate Oxidase; Disease Models, Animal; DNA Methylation; Excitatory Amino Acid Antagonists; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Middle Aged; Motor Activity; Phencyclidine; Prefrontal Cortex; Prepulse Inhibition; Schizophrenia | 2015 |
Evolution and synthesis of novel orally bioavailable inhibitors of PDE10A.
Topics: Administration, Oral; Animals; Biological Availability; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Humans; Locomotion; Models, Molecular; Molecular Structure; Phencyclidine; Phosphoric Diester Hydrolases; Rats; Structure-Activity Relationship; Triazoles | 2015 |
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Cognition; Cognition Disorders; Disease Models, Animal; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Memory; Mice; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Social Behavior | 2015 |
Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.
Topics: Acoustic Stimulation; Animals; Disease Models, Animal; Long-Term Potentiation; Male; Phencyclidine; Phosphorylation; Prefrontal Cortex; Prepulse Inhibition; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Sensory Gating; Signal Transduction | 2016 |
PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Hippocampus; Male; Memory, Short-Term; Mice; Motor Activity; Neostriatum; Phencyclidine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Receptors, N-Methyl-D-Aspartate; Reversal Learning; Schizophrenia | 2015 |
Addressing phototoxicity observed in a novel series of biaryl derivatives: discovery of potent, selective and orally active phosphodiesterase 10A inhibitor ASP9436.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Behavior, Animal; Benzimidazoles; Binding Sites; Crystallography, X-Ray; Disease Models, Animal; Hallucinogens; Humans; Male; Mice; Mice, Inbred ICR; Pattern Recognition, Visual; Phencyclidine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Photochemical Processes; Protein Binding; Pyridines; Quinolines; Schizophrenia; Ultraviolet Rays | 2015 |
Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
Topics: Animals; Apoptosis; Chromatography, Liquid; Cytokines; Disease Models, Animal; Frontal Lobe; Hallucinogens; Hippocampus; Humans; Male; Mass Spectrometry; Metabolome; Metabolomics; Oxidative Stress; Phencyclidine; Proteome; Proteomics; Rats, Sprague-Dawley; Schizophrenia; Signal Transduction; Superoxide Dismutase; Synaptic Transmission | 2015 |
Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood.
Topics: Adolescent; Adult; Animals; Brassica; Child; Cognition Disorders; Disease Models, Animal; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Mice; Middle Aged; NF-E2-Related Factor 2; Oxidative Stress; Phencyclidine; Plant Extracts; Prefrontal Cortex; Schizophrenia; Seedlings; Sulfoxides | 2015 |
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.
Topics: Animals; Antipsychotic Agents; Cognition; Disease Models, Animal; Long-Term Synaptic Depression; Male; Mice, Inbred C57BL; Mice, Knockout; Patch-Clamp Techniques; Phencyclidine; Pyridines; Pyrroles; Receptor, Muscarinic M1; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.
Topics: Animals; Antipsychotic Agents; Arrestins; beta-Arrestins; Catalepsy; Disease Models, Animal; Dopamine Agents; Drug Evaluation, Preclinical; Female; Glutamic Acid; Male; Mice, 129 Strain; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Phencyclidine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Role of the nitric oxide donor sodium nitroprusside in the antidepressant effect of ketamine in mice.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ketamine; Male; Mice, Inbred C57BL; Motor Activity; Nitric Oxide Donors; Nitroprusside; Phencyclidine; Receptors, N-Methyl-D-Aspartate | 2015 |
Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoindoles; Lurasidone Hydrochloride; Phencyclidine; Piperazines; Psychotropic Drugs; Pyridines; Pyrimidines; Random Allocation; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Schizophrenic Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Time | 2016 |
Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
Topics: Animals; Bacopa; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Nootropic Agents; Phencyclidine; Phytotherapy; Prefrontal Cortex; Rats; Rats, Wistar; Schizophrenia; Vesicular Glutamate Transport Protein 1 | 2015 |
Effects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Male; Nicotine; Phencyclidine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Schizophrenia; Smoking; Ultrasonics; Vocalization, Animal | 2016 |
THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
Topics: Animals; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Dronabinol; Endocannabinoids; Hippocampus; Male; Phencyclidine; Polyunsaturated Alkamides; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Up-Regulation | 2016 |
Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Azetidines; Benzamides; Bridged Bicyclo Compounds; Cognition Disorders; Disease Models, Animal; Female; Lurasidone Hydrochloride; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Phencyclidine; Random Allocation; Rats, Long-Evans; Receptors, Nicotinic | 2016 |
GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.
Topics: Animals; Cognition; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ketamine; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Oligopeptides; Phencyclidine; Recognition, Psychology | 2016 |
Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Topics: Animals; Antipsychotic Agents; Cognition; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Female; Motor Activity; Nootropic Agents; Phencyclidine; Piperazines; Rats; Recognition, Psychology; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Attention; Disease Models, Animal; Dopamine Agonists; Female; Inhibition, Psychological; Neuropsychological Tests; Phencyclidine; Psychomotor Performance; Psychotropic Drugs; Rats; Receptors, Dopamine D1; Schizophrenic Psychology; Treatment Outcome | 2016 |
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
Topics: Analysis of Variance; Animals; Cannabinoid Receptor Modulators; Cyclohexanols; Discrimination, Psychological; Disease Models, Animal; Endocannabinoids; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Odorants; Phencyclidine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Social Behavior Disorders; Social Perception | 2016 |
The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Association Learning; Developmental Disabilities; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Interpersonal Relations; Locomotion; Male; Memory Disorders; Phencyclidine; Piperazines; Rats; Recognition, Psychology; Schizophrenia | 2016 |
mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Topics: Amino Acids; Animals; Antipsychotic Agents; Benzodiazepines; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nucleus Accumbens; Olanzapine; Phencyclidine; Prefrontal Cortex; Protein Binding; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2016 |
Comparison of phencyclidine-induced spatial learning and memory deficits and reversal by sertindole and risperidone between Lister Hooded and Wistar rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Imidazoles; Indoles; Learning Disabilities; Male; Maze Learning; Memory Disorders; Phencyclidine; Rats; Rats, Wistar; Risperidone; Spatial Learning; Spatial Navigation | 2016 |
Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; CHO Cells; Cognition Disorders; Cricetulus; Cyclic AMP; Disease Models, Animal; HEK293 Cells; Humans; Male; Neuroblastoma; Phencyclidine; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Sulfones | 2016 |
Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model.
Topics: Affect; Animals; Behavior, Animal; Disease Models, Animal; Female; Phencyclidine; Rats; Reward; Schizophrenia; Schizophrenic Psychology | 2016 |
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
Topics: Animals; Chromatography, Liquid; Disease Models, Animal; Humans; Ketamine; Machine Learning; Male; Mice, Transgenic; Phencyclidine; Prefrontal Cortex; Protein Interaction Maps; Proteomics; Psychotic Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tandem Mass Spectrometry | 2016 |
Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.
Topics: Animals; Animals, Newborn; Behavior, Animal; Disease Models, Animal; Dopaminergic Neurons; GABAergic Neurons; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Glutamic Acid; Hippocampus; Lamotrigine; Locomotion; Male; Oligonucleotide Array Sequence Analysis; Phencyclidine; Phenotype; Prepulse Inhibition; Rats, Inbred Strains; Recognition, Psychology; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Social Isolation; Sodium Channel Blockers; Synaptic Transmission; Time Factors; Triazines; Weaning | 2016 |
Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.
Topics: Animals; Bacopa; Brain; Disease Models, Animal; Male; Phencyclidine; Plant Extracts; Rats; Rats, Wistar; Recognition, Psychology; Schizophrenia; Vesicular Glutamate Transport Proteins | 2016 |
Trans-generation enrichment of clozapine-responsiveness trait in mice using a subchronic hypo-glutamatergic model of schizophrenia:A preliminary study.
Topics: Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Female; Frontal Lobe; Glutamate Decarboxylase; Glutamic Acid; Hippocampus; Male; Mice; Mice, Inbred C57BL; Phencyclidine; Schizophrenia; Selective Breeding; Social Behavior | 2017 |
Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies.
Topics: Adult; Aged; Animals; Animals, Newborn; Disease Models, Animal; Excitatory Amino Acid Antagonists; F-Box Proteins; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Phencyclidine; Postmortem Changes; Protein Inhibitors of Activated STAT; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Schizophrenia; Ubiquitin Thiolesterase; Ubiquitin-Conjugating Enzymes; Ubiquitins | 2017 |
Short- and long-term behavioral analysis of social interaction, ultrasonic vocalizations and social motivation in a chronic phencyclidine model.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Hallucinogens; Interpersonal Relations; Male; Motivation; Phencyclidine; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Ultrasonic Waves; Vocalization, Animal | 2017 |
Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia.
Topics: Action Potentials; Animals; Disease Models, Animal; Female; Hallucinogens; Memory Disorders; Neural Pathways; Neurons; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Rats; Recognition, Psychology; Schizophrenia | 2017 |
Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication.
Topics: Alcoholic Intoxication; Animals; Ataxia; Central Nervous System Depressants; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Ethanol; Female; Hypothermia; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Phencyclidine; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2008 |
Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Topics: Amygdala; Animals; Cerebral Cortex; Dentate Gyrus; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hippocampus; Limbic System; Muscarinic Antagonists; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptor Aggregation; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Time Factors | 2008 |
Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Hallucinogens; Hippocampus; Interpersonal Relations; Male; Motor Activity; Parvalbumins; Phencyclidine; Rats; Schizophrenia; Time Factors | 2008 |
A primate model of schizophrenia using chronic PCP treatment.
Topics: Amphetamine; Animals; Behavior, Animal; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Synergism; Female; Hallucinogens; Interpersonal Relations; Macaca fascicularis; Male; Phencyclidine; Schizophrenia; Social Behavior | 2008 |
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
Topics: Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Disease Models, Animal; Endocannabinoids; Male; Phencyclidine; Rats; Receptor, Cannabinoid, CB1; Schizophrenia | 2009 |
Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Clonidine; Disease Models, Animal; Dopamine; Guanfacine; Imidazoles; Isoindoles; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Schizophrenia | 2008 |
Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Clozapine; Disease Models, Animal; Haloperidol; Hyperkinesis; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Time Factors | 2009 |
Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide.
Topics: Acoustic Stimulation; Animals; Baclofen; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electrochemistry; Enzyme Inhibitors; GABA Agonists; Male; Mice; Mice, Inbred Strains; Neural Inhibition; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phencyclidine; Prefrontal Cortex; Receptors, GABA-B; Reflex, Startle; Signal Transduction | 2009 |
Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Dextroamphetamine; Disease Models, Animal; Drug Interactions; Motivation; Motor Activity; Olanzapine; Phencyclidine; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Schizophrenic Psychology | 2009 |
D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Behavior, Animal; Benzazepines; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Neuropsychological Tests; Phencyclidine; Receptors, Dopamine D1; Recognition, Psychology | 2009 |
Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopamine; Extracellular Space; Hyperkinesis; Male; Morphinans; Naltrexone; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Schizophrenia; Serotonin; Spiro Compounds | 2009 |
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
Topics: Animals; Antipsychotic Agents; Attention; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Indoles; Male; Phencyclidine; Piperidines; Rats; Schizophrenia | 2009 |
Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Dentate Gyrus; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Hippocampus; Male; Memory Disorders; Motor Activity; Neurogenesis; Phencyclidine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 2009 |
Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Phencyclidine; Phenotype; Reflex, Startle; Schizophrenia; Species Specificity | 2009 |
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Animals; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Hyperkinesis; Ketamine; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2009 |
Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Phencyclidine; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Reversal Learning; Schizophrenia; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.
Topics: Action Potentials; Animals; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamate Decarboxylase; Male; Neural Inhibition; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Phencyclidine; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Schizophrenia; Synaptic Transmission | 2009 |
Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antipsychotic Agents; Brain; Cognition; Cognition Disorders; Dibenzothiazepines; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Phencyclidine; Prazosin; Quetiapine Fumarate; Receptors, Adrenergic, alpha-1; Time Factors | 2009 |
Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Topics: Animals; Body Weight; Disease Models, Animal; Dizocilpine Maleate; Male; Memory, Short-Term; Motor Activity; Phencyclidine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Social Behavior; Substance Withdrawal Syndrome | 2009 |
The effect of mGlu8 deficiency in animal models of psychiatric diseases.
Topics: Animals; Anxiety Disorders; Chlordiazepoxide; Conditioning, Operant; Conditioning, Psychological; Disease Models, Animal; Extinction, Psychological; Fear; Hyperkinesis; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pattern Recognition, Visual; Phencyclidine; Receptors, Metabotropic Glutamate; Reflex, Startle | 2010 |
Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Berberine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Guanosine 5'-O-(3-Thiotriphosphate); Inhibition, Psychological; Interpersonal Relations; Locomotion; Male; Phencyclidine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Recognition, Psychology; Reflex, Startle; Schizophrenia | 2009 |
Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Topics: Animals; Antipsychotic Agents; Attention; Behavior, Animal; Behavioral Sciences; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Hallucinogens; Infusion Pumps, Implantable; Male; Modafinil; Neuropharmacology; Neuropsychological Tests; Neurosciences; Phencyclidine; Rats; Schizophrenia; Schizophrenic Psychology | 2009 |
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Imidazoles; Indoles; Memory Disorders; Phencyclidine; Piperidines; Quinolines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reversal Learning; Schizophrenia; Sulfones | 2010 |
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.
Topics: Acoustic Stimulation; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Disease Models, Animal; Drug Administration Routes; Interpersonal Relations; Male; Morpholines; Naphthalenes; Neural Inhibition; Phencyclidine; Psychomotor Performance; Rats; Recognition, Psychology; Reflex, Startle; Schizophrenia; Self Administration; Statistics, Nonparametric | 2010 |
The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
Topics: Amino Acids; Animals; Antipsychotic Agents; Biogenic Monoamines; Central Nervous System Agents; Disease Models, Animal; Dopamine; Extracellular Space; Glutamic Acid; Glycine; Male; Motor Activity; Neurotensin; Norepinephrine; Peptide Fragments; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2010 |
Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia.
Topics: Allosteric Regulation; Animals; Avoidance Learning; Disease Models, Animal; Locomotion; Oxadiazoles; Phencyclidine; Piperidines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia | 2010 |
Identification of targeted analyte clusters for studies of schizophrenia.
Topics: Adult; Animals; Biomarkers; Bipolar Disorder; Cluster Analysis; Depressive Disorder, Major; Disease Models, Animal; Electronic Data Processing; Female; Hallucinogens; Humans; Male; Phencyclidine; Proteomics; Rats; Schizophrenia; Signal Transduction | 2010 |
Multiple 'hits' during postnatal and early adulthood periods disrupt the normal development of sensorimotor gating ability in rats.
Topics: Age Factors; Animals; Avoidance Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hallucinogens; Male; Maternal Deprivation; Phencyclidine; Pregnancy; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Sensory Gating; Time Factors | 2011 |
Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.
Topics: Affective Symptoms; Animals; Choice Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Hippocampus; Immunohistochemistry; Male; Neurons; Parvalbumins; Phencyclidine; Pleasure; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Sucrose; Taste | 2010 |
Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Feeding Behavior; Male; Motor Activity; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Reward; Schizophrenia; Schizophrenic Psychology; Sucrose; Taste; Time Factors | 2010 |
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Modulators; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Male; Motor Activity; Phencyclidine; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Schizophrenia; Time Factors | 2011 |
Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia--gating of auditory-evoked potentials and prepulse inhibition.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Evoked Potentials, Auditory; Phencyclidine; Rats; Rats, Inbred Strains; Schizophrenia; Sensory Gating | 2010 |
F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Cognition; Disease Models, Animal; Enzyme Inhibitors; Male; Memory, Short-Term; Phencyclidine; Piperidines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex, Startle; Serotonin 5-HT1 Receptor Agonists; Signal Transduction | 2010 |
Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.
Topics: Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Down-Regulation; Glutamic Acid; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phencyclidine; Polymerase Chain Reaction; Prefrontal Cortex; Receptors, Neurotensin; RNA, Messenger; Schizophrenia; Schizophrenic Psychology; Swimming; Up-Regulation | 2010 |
Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.
Topics: Animals; Brain; Cluster Analysis; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fluoresceins; Gene Expression; Gene Expression Profiling; Microarray Analysis; Molecular Sequence Data; Nerve Degeneration; Phencyclidine; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Schizophrenia | 2011 |
Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model.
Topics: Animals; Antipsychotic Agents; Attention; Behavior, Animal; Benzhydryl Compounds; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Executive Function; Haloperidol; Male; Modafinil; Neuropsychological Tests; Phencyclidine; Rats; Recombinant Proteins; Reward; Schizophrenia; Schizophrenic Psychology | 2010 |
Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Brain; Cognition; Disease Models, Animal; Electrochemical Techniques; Enzyme Inhibitors; Ion-Selective Electrodes; Male; Neural Inhibition; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phencyclidine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Time Factors; Up-Regulation | 2010 |
Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity.
Topics: Animals; Autoradiography; Behavior, Animal; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cognition; Disease Models, Animal; Hallucinogens; Male; Modafinil; Neural Pathways; Phencyclidine; Rats | 2012 |
Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine.
Topics: Animals; Antipsychotic Agents; Attention; Choice Behavior; Clozapine; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; GABA Antagonists; Male; Phencyclidine; Rats; Rats, Long-Evans; Reaction Time; Receptors, N-Methyl-D-Aspartate; Signal Detection, Psychological; Time Factors | 2011 |
Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Estrous Cycle; Exploratory Behavior; Female; GABA-A Receptor Agonists; Isoxazoles; Motor Activity; Phencyclidine; Rats; Receptors, GABA-A; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Time Factors | 2011 |
PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia.
Topics: Animals; Benzamides; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Phencyclidine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine D4; Recognition, Psychology; Schizophrenic Psychology | 2011 |
Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.
Topics: Animals; Blotting, Western; Brain; Disease Models, Animal; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Immunohistochemistry; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Parvalbumins; Phencyclidine; Racemases and Epimerases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2011 |
Evaluation of object-based attention in mice.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fenclonine; Inhibition, Psychological; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Norepinephrine; Phencyclidine; Recognition, Psychology; Serotonin; Serotonin Antagonists | 2011 |
[Development of animal models, and drug discovery for schizophrenia based on the glutamate hypothesis].
Topics: Animals; Disease Models, Animal; Drug Discovery; Glutamic Acid; Humans; Mice; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2010 |
[Development of psychotropic agents for schizophrenia based on the glutamate hypothesis].
Topics: Animals; Disease Models, Animal; Drug Discovery; Glutamic Acid; Humans; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Serine | 2010 |
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Topics: Animals; Bridged Bicyclo Compounds; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glutamate Carboxypeptidase II; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organophosphorus Compounds; Phencyclidine; Receptors, Metabotropic Glutamate; Reflex, Startle; Schizophrenia; Species Specificity; Urea | 2011 |
Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition.
Topics: Algorithms; Animals; Cluster Analysis; Cognition; Disease Models, Animal; Gene Expression Regulation; Genome; Glutamic Acid; Humans; Ligands; Models, Biological; Models, Statistical; Phencyclidine; Principal Component Analysis; Rats; Schizophrenia; Software; Systems Biology | 2011 |
Chronic administration of phencyclidine produces decreased sensitivity to mechanical stimulation in the absence of altered affective behavior: Implications for pain processing in schizophrenia.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Clozapine; Disease Models, Animal; Escape Reaction; Excitatory Amino Acid Antagonists; Ligation; Male; Neuralgia; Pain Perception; Phencyclidine; Physical Stimulation; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Spinal Nerves; Stress, Mechanical | 2011 |
Loss of asymmetric spine synapses in dorsolateral prefrontal cortex of cognitively impaired phencyclidine-treated monkeys.
Topics: Animals; Chlorocebus aethiops; Cognition; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Male; Microscopy, Electron, Transmission; Phencyclidine; Prefrontal Cortex; Schizophrenia; Schizophrenic Psychology; Synapses | 2011 |
Is the acute NMDA receptor hypofunction a valid model of schizophrenia?
Topics: Animals; Corpus Callosum; Disease Models, Animal; Dopamine; Glutamic Acid; Humans; Ketamine; Parvalbumins; Phencyclidine; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Rodentia; Schizophrenia; Serotonin | 2012 |
Repeated ethanol but not phencyclidine impairs spontaneous alternation behaviour in the Y-maze.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Drug Administration Schedule; Ethanol; Hallucinogens; Male; Maze Learning; Motor Activity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar | 2012 |
Phencyclidine treatment increases NR2A and NR2B N-methyl-D-aspartate receptor subunit expression in rats.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Male; Phencyclidine; Pregnancy; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Up-Regulation | 2011 |
Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.
Topics: Action Potentials; Amygdala; Animals; Area Under Curve; Biophysics; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Extinction, Psychological; Fear; Glutamate Decarboxylase; Hippocampus; In Vitro Techniques; Male; Memory Disorders; Neurons; Parvalbumins; Patch-Clamp Techniques; Phencyclidine; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Schizophrenia; Synaptic Transmission; Time Factors | 2012 |
Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.
Topics: Amphetamine; Animals; Benzodiazepines; Central Nervous System Stimulants; CHO Cells; Cognition Disorders; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperkinesis; Imidazoles; Male; Oocytes; Parvalbumins; Phencyclidine; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, GABA-A; Schizophrenia; Xenopus laevis | 2012 |
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention; Behavior, Animal; Brain; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Drug Interactions; Female; Half-Life; Hallucinogens; Isoxazoles; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotinic Agonists; Phencyclidine; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Tissue Distribution | 2012 |
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Cognition; Disease Models, Animal; Fluorobenzenes; Locomotion; Male; Phencyclidine; Phenols; Piperidines; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Recognition, Psychology; Serotonin Antagonists; Sulfonamides | 2012 |
mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamate Carboxypeptidase II; Mice; Mice, Knockout; Motor Activity; Organophosphorus Compounds; Phencyclidine; Receptors, Metabotropic Glutamate; Schizophrenia | 2012 |
Phencyclidine/schizophrenia: one view toward the past, the other to the future.
Topics: Anesthetics; Animals; Disease Models, Animal; History, 20th Century; History, 21st Century; Humans; Illicit Drugs; Neuropharmacology; Phencyclidine; Psychoses, Substance-Induced; Schizophrenia | 2012 |
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.
Topics: Animals; Disease Models, Animal; Frontal Lobe; Fructose-Bisphosphate Aldolase; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Hexokinase; Humans; Male; Metabolic Networks and Pathways; Multivariate Analysis; Phencyclidine; Phosphoglycerate Kinase; Phosphoglycerate Mutase; Phosphopyruvate Hydratase; Rats; Schizophrenia; Triose-Phosphate Isomerase | 2012 |
Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
Topics: Analysis of Variance; Animals; Cognition Disorders; Disease Models, Animal; Estradiol; Estrogens; Exploratory Behavior; Female; Hallucinogens; Motor Activity; Neuropsychological Tests; Ovariectomy; Phencyclidine; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Statistics, Nonparametric; Time Factors | 2012 |
Cholinergic denervation attenuates phencyclidine-induced c-fos responses in rat cortical neurons.
Topics: Animals; Antibodies, Monoclonal; Behavior, Animal; Brain; Cholinergic Agents; Denervation; Disease Models, Animal; Male; Neurons; Phencyclidine; Proto-Oncogene Proteins c-fos; Rats; Ribosome Inactivating Proteins, Type 1; Saporins; Schizophrenia | 2012 |
Deficits in emotional learning and memory in an animal model of schizophrenia.
Topics: Analysis of Variance; Animals; Brain; Conditioning, Classical; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fear; Hindlimb Suspension; Ketamine; Learning Disabilities; Male; Memory Disorders; Phencyclidine; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, GABA-B; Schizophrenia; Sensory Gating | 2012 |
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Glutamate Carboxypeptidase II; Glutamic Acid; Male; Neurotransmitter Agents; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia | 2012 |
Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Brain; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Exploratory Behavior; Male; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurons; Phencyclidine; Pyrazoles; Receptor, Metabotropic Glutamate 5; Recognition, Psychology; Schizophrenia | 2013 |
Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission.
Topics: Analysis of Variance; Animals; Blood Proteins; Disease Models, Animal; Energy Metabolism; Frontal Lobe; Glucose; Hippocampus; Humans; Insulin; Male; Motor Activity; Multivariate Analysis; Phencyclidine; Proteome; Rats; Rats, Sprague-Dawley; Schizophrenia; Synaptic Transmission | 2012 |
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Attention; Benzodiazepines; Body Weight; Cocaine; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Electroencephalography; Hallucinogens; Haloperidol; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Mental Recall; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microinjections; Motor Activity; Mutation; Olanzapine; Oocytes; Oxazoles; Phencyclidine; Phenethylamines; Protein Binding; Pyrrolidinones; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reinforcement, Psychology; Schizophrenia; Swimming; Telemetry; Tritium; Xenopus | 2013 |
[JSNP Excellent Presentation Award for AsCNP 2011: enriched environment in adolescence prevents abnormal behavior associated with histone deacetylation in phencyclidine-treated mice].
Topics: Acetylation; Aging; Animals; Awards and Prizes; Behavior, Animal; Disease Models, Animal; Histone Deacetylases; Histones; Male; Mice; Phencyclidine; Social Behavior | 2012 |
[JSNP Excellent Presentation Award for AsCNP 2011: combination of a neonatal viral infection with an adolescent substance use affect psychological function in adult].
Topics: Age Factors; Animals; Animals, Newborn; Awards and Prizes; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Mice; Models, Psychological; Phencyclidine; Poly I-C; Substance-Related Disorders | 2012 |
Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain.
Topics: Animals; Antioxidants; Antipsychotic Agents; Brain; Disease Models, Animal; Female; Glutamate-Cysteine Ligase; Glutathione; Lipid Peroxidation; Male; Phencyclidine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Risperidone; Schizophrenia | 2012 |
Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Isoindoles; Lurasidone Hydrochloride; Phencyclidine; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Thiazoles; Urea | 2012 |
Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia.
Topics: Animals; Behavior, Animal; Brain; Demyelinating Diseases; Disease Models, Animal; Motor Activity; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2012 |
Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice.
Topics: Adult Stem Cells; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Clozapine; Disease Models, Animal; Humans; Mesenchymal Stem Cell Transplantation; Mice; Phencyclidine; Prefrontal Cortex; Social Behavior; Up-Regulation | 2011 |
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.
Topics: Animals; Anxiety; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Injections, Intravenous; Male; Morpholines; Motor Activity; Naphthalenes; Phencyclidine; Rats; Rats, Inbred Strains; Schizophrenia; Schizophrenic Psychology; Self Administration | 2013 |
Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats.
Topics: Age Factors; Animals; Animals, Newborn; Autoradiography; Brain; Cell Count; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation, Developmental; Male; Motor Activity; Neuroglia; Neurons; Parvalbumins; Phencyclidine; Phosphopyruvate Hydratase; Rats; RNA, Messenger; Schizophrenia; Social Isolation | 2013 |
Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.
Topics: Acetylcysteine; Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Animals; Benzoates; Disease Models, Animal; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Glycine; In Situ Hybridization; Male; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reflex, Startle; RNA, Messenger; Schizophrenia; Sensory Gating | 2013 |
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.
Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Ketamine; Nitroso Compounds; Phencyclidine; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Sulfur Radioisotopes | 2002 |
Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Male; Parvalbumins; Phencyclidine; Prefrontal Cortex; Rats; Rats, Long-Evans; Schizophrenia; Thalamus | 2003 |
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.
Topics: Animals; Disease Models, Animal; Immobilization; Male; Mice; Motor Activity; Phencyclidine; Piperazines; Piperidines; Schizophrenia | 2003 |
Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Benzylamines; Brain; Carbachol; Central Nervous System Stimulants; Cholinergic Agonists; Conditioning, Psychological; Discrimination Learning; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Escape Reaction; Excitatory Amino Acid Antagonists; Extracellular Space; Male; Microdialysis; Motor Activity; Neurons; Neurotransmitter Agents; Phencyclidine; Rats; Reaction Time; Serotonin; Serotonin Agents; Social Isolation; Stress, Physiological | 2003 |
Synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Blotting, Northern; Blotting, Western; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Tissue Proteins; Nucleus Accumbens; Phencyclidine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; SAP90-PSD95 Associated Proteins; Schizophrenia | 2003 |
Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia.
Topics: Aging; Amphetamine; Animals; Animals, Newborn; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Male; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Reaction Time; Schizophrenia | 2003 |
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Behavior, Animal; Cebus; Clozapine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Excitatory Amino Acid Antagonists; Female; Haloperidol; Neural Inhibition; Phencyclidine; Reflex, Startle; Schizophrenia | 2003 |
Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophrenia.
Topics: Amygdala; Animals; Animals, Newborn; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Hypersensitivity; Early Ambulation; Excitatory Amino Acid Antagonists; Exploratory Behavior; Habituation, Psychophysiologic; Hyperkinesis; Male; Motor Activity; Phencyclidine; Rats; Rats, Wistar; Schizophrenia; Stereotyped Behavior | 2003 |
Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.
Topics: 5,7-Dihydroxytryptamine; Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperkinesis; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Tissue Proteins; Neural Inhibition; Phencyclidine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Startle; Schizophrenia; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2003 |
Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
Topics: Animals; Antineoplastic Agents; Apomorphine; Brain; Cytarabine; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Female; Hallucinogens; Male; Maternal-Fetal Exchange; Phencyclidine; Pregnancy; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2004 |
Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients.
Topics: Animals; Disease Models, Animal; Hallucinogens; Humans; Male; Mice; Mice, Inbred Strains; Nicotine; Phencyclidine; Schizophrenia; Smoking Prevention; Species Specificity | 2004 |
Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task.
Topics: Animals; Attention; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Feeding Behavior; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Motor Activity; Odorants; Phencyclidine; Reward; Schizophrenic Psychology | 2004 |
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
Topics: Animals; Behavior, Animal; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Male; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schizophrenia; Stereotyped Behavior; Urea | 2004 |
(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Male; Motor Activity; Neurotoxicity Syndromes; Phencyclidine; Rats; Rats, Wistar; Schizophrenia; Social Behavior; Stereotyped Behavior | 2004 |
Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain.
Topics: Animals; Aspartic Acid; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Frontal Lobe; Hallucinogens; Hippocampus; Male; Phencyclidine; Psychotic Disorders; Rats; Rats, Long-Evans; Temporal Lobe | 2005 |
Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Animals, Newborn; Brain; Brain Mapping; Disease Models, Animal; Dose-Response Relationship, Radiation; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Models, Neurological; Oxygen; Phencyclidine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reflex, Startle; Schizophrenia | 2005 |
Ontogenetic study of metaphit-induced audiogenic seizures in rats.
Topics: Acoustic Stimulation; Age Factors; Animals; Animals, Newborn; Brain; Convulsants; Disease Models, Animal; Drug Resistance; Epilepsy, Reflex; Female; Genetic Predisposition to Disease; Male; Neural Pathways; Phencyclidine; Rats; Rats, Wistar; Reaction Time; Seizures; Synaptic Transmission | 2005 |
PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
Topics: Analysis of Variance; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Papaverine; Phencyclidine; Phosphodiesterase Inhibitors; Rats; Rats, Long-Evans | 2005 |
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Clozapine; Dextroamphetamine; Dioxanes; Discrimination, Psychological; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Imipramine; Injections, Intraperitoneal; Male; Phencyclidine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Recognition, Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Social Behavior; Tacrine; Tropanes | 2005 |
Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum.
Topics: Animals; Conditioning, Operant; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Injections, Intraventricular; Kainic Acid; Male; Neurotoxicity Syndromes; Oxidopamine; Phencyclidine; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule | 2005 |
Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin.
Topics: Acoustic Stimulation; Animals; Auditory Perception; Behavior, Animal; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fear; Humans; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Secretin | 2005 |
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.
Topics: Animals; Ataxia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Genotype; Humans; Male; Mice; Mice, Knockout; Motor Activity; Phencyclidine; Receptor, Cannabinoid, CB1; Schizophrenia; Schizophrenic Psychology; Social Isolation | 2005 |
Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Drug Interactions; Hyperkinesis; Lamotrigine; Male; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Time Factors; Triazines | 2006 |
Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Female; Gene Expression; Hippocampus; Immunohistochemistry; Methylazoxymethanol Acetate; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2006 |
The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Phencyclidine; Rats; Receptors, N-Methyl-D-Aspartate; Reversal Learning | 2006 |
Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.
Topics: Animals; Behavior, Animal; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Hippocampus; Immunohistochemistry; Male; Neurons; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2006 |
Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Topics: Acoustic Stimulation; Adrenergic alpha-Agonists; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Gait Disorders, Neurologic; Imidazoles; Isoxazoles; Male; Neural Inhibition; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle | 2006 |
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia.
Topics: Acoustic Stimulation; Animals; Brain Chemistry; Cyclic GMP; D-Amino-Acid Oxidase; Disease Models, Animal; Dose-Response Relationship, Radiation; Excitatory Amino Acid Antagonists; Extremities; Female; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Motor Activity; Neural Inhibition; Neurologic Examination; Phencyclidine; Psychomotor Performance; Quinolones; Reaction Time; Reflex, Startle; Schizophrenia; Sex Factors; Swimming | 2006 |
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recognition, Psychology; Schizophrenia | 2007 |
The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats.
Topics: Age Factors; Animals; Animals, Newborn; Apoptosis; Brain; Caspase 3; Cell Death; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; In Situ Nick-End Labeling; Male; Nerve Degeneration; Organ Culture Techniques; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Time Factors | 2007 |
Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats.
Topics: Acoustic Stimulation; Age Factors; Animals; Animals, Newborn; Arousal; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Inhibition, Psychological; Injections, Subcutaneous; Male; Phencyclidine; Phencyclidine Abuse; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenic Psychology; Sex Factors | 2007 |
Neonatal handling prevents the effects of phencyclidine in an animal model of negative symptoms of schizophrenia.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Animals, Newborn; Disease Models, Animal; Exploratory Behavior; Female; Handling, Psychological; Immunoassay; Male; Phencyclidine; Rats; Rats, Wistar; Restraint, Physical; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; Swimming | 2007 |
The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice.
Topics: Amino Acid Transport Systems, Basic; Amino Acids; Animals; Arginine; Behavior, Animal; Biological Transport; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Hallucinogens; Lysine; Male; Mice; Nitric Oxide; Phencyclidine; Reflex; Reflex, Startle; Schizophrenia | 2007 |
Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex.
Topics: Analysis of Variance; Animals; Axons; Calbindin 2; Chlorocebus aethiops; Disease Models, Animal; Excitatory Amino Acid Antagonists; Immunohistochemistry; Male; Neuronal Plasticity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pyramidal Cells; S100 Calcium Binding Protein G; Schizophrenia | 2007 |
Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
Topics: Animals; Brain; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Phencyclidine; Piperidines; Psychoses, Substance-Induced; Pyrazoles; Rats; Receptors, Cannabinoid; Reflex, Startle; Rimonabant; Schizophrenia; Sensation Disorders; Synaptic Transmission | 2007 |
Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Galantamine; Interpersonal Relations; Male; Mice; Mice, Inbred ICR; Microdialysis; Nootropic Agents; Phencyclidine; Prefrontal Cortex; Risperidone; Schizophrenia | 2007 |
Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Eating; Hallucinogens; Haloperidol; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Reward; Schizophrenia; Sucrose | 2007 |
Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Topics: Animals; Behavior, Animal; Cognition Disorders; Conditioning, Operant; Dentate Gyrus; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Hallucinogens; Hippocampus; Immunohistochemistry; Interneurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Rats; Reversal Learning; Schizophrenia | 2007 |
Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Male; Methamphetamine; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2007 |
The neuronal pathology of schizophrenia: molecules and mechanisms.
Topics: Animals; Aspartic Acid; Brain; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; Neurons; Phencyclidine; Schizophrenia | 2007 |
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mental Disorders; Mice; Molecular Structure; Motor Activity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Xanthenes | 2007 |
Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine.
Topics: Animals; Behavior, Animal; Cebus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycine; Glycine Agents; Hallucinogens; Male; Motor Activity; Phencyclidine; Schizophrenia; Stereotyped Behavior; Stress, Psychological | 2007 |
Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
Topics: Animals; Binding, Competitive; Brain; Brain Chemistry; Disease Models, Animal; Dizocilpine Maleate; Down-Regulation; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Hippocampus; Mice; Mice, Inbred C57BL; Phencyclidine; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Time Factors | 2007 |
Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Imidazoles; Indoles; Male; Maze Learning; Phencyclidine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenic Psychology | 2007 |
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
Topics: Amphetamine; Animals; Anticonvulsants; Anxiety; Autoreceptors; Benzoates; Brain; Central Nervous System Stimulants; Dentate Gyrus; Disease Models, Animal; Electroshock; Glycine; Humans; Male; Mice; Mice, Knockout; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schizophrenia; Seizures; Synapses; Synaptic Transmission | 2007 |
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Topics: Animals; Antipsychotic Agents; Attention; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Haloperidol; Impulsive Behavior; Male; Olanzapine; Phencyclidine; Quetiapine Fumarate; Rats; Rats, Wistar; Reaction Time; Risperidone; Schizophrenia | 2007 |
Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
Topics: Agonistic Behavior; Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamate Carboxypeptidase II; Male; Mice; Phencyclidine; Receptors, Metabotropic Glutamate; Schizophrenia; Stereotyped Behavior; Urea | 2008 |
Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Female; Motor Activity; Phencyclidine; Rats; Recognition, Psychology | 2007 |
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Amino Acids; Analysis of Variance; Animals; Behavior, Animal; Cell Line, Transformed; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Fluid; Female; Free Radical Scavengers; Glutamic Acid; Glycine; Humans; Interpersonal Relations; Male; Maze Learning; Microdialysis; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Xanthenes | 2008 |
Synapsin II knockout mice show sensorimotor gating and behavioural abnormalities similar to those in the phencyclidine-induced preclinical animal model of schizophrenia.
Topics: Animals; Arousal; Attention; Disease Models, Animal; Mice; Mice, Knockout; Neural Inhibition; Phencyclidine; Prefrontal Cortex; Reflex, Startle; Schizophrenia; Social Behavior; Stereotyped Behavior; Synapsins | 2007 |
Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Gene Expression Regulation; Genes, Immediate-Early; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Phencyclidine; Prefrontal Cortex; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Schizophrenia; Transcriptional Activation | 2008 |
Interaction of Delta sleep-inducing peptide and valproate on metaphit audiogenic seizure model in rats.
Topics: Animals; Anticonvulsants; Delta Sleep-Inducing Peptide; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Epilepsy, Reflex; Male; Phencyclidine; Rats; Rats, Wistar; Valproic Acid | 2007 |
Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
Topics: Age Factors; Animals; Animals, Newborn; Body Temperature; Body Temperature Regulation; Body Weight; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Phencyclidine; Pregnancy; Rats; Rats, Wistar; Schizophrenia | 2008 |
Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Matched-Pair Analysis; Phencyclidine; Piperazines; Rats; Rats, Inbred Strains; Schizophrenia; Schizophrenic Psychology; Social Behavior; Social Behavior Disorders; Thiazoles | 2008 |
Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons.
Topics: Animals; Animals, Newborn; Apoptosis; Bromodeoxyuridine; Calbindin 2; Calbindins; Caspase 3; Cell Count; Cell Proliferation; Cell Survival; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Interneurons; Male; Parvalbumins; Phencyclidine; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein G; Schizophrenia; Time | 2008 |
Moderate body hypothermia alleviates behavioral and EEG manifestations of audiogenic seizures in metaphit-treated rats.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Body Temperature; Brain; Disease Models, Animal; Electroencephalography; Hypothermia, Induced; Male; Phencyclidine; Rats; Rats, Wistar; Seizures | 2007 |
Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting.
Topics: Age Factors; Animals; Animals, Newborn; Attention; Behavior, Animal; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Male; Odorants; Phencyclidine; Pregnancy; Rats; Schizophrenia; Sex Factors | 2008 |
Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
Topics: 2-Amino-5-phosphonovalerate; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Male; Maze Learning; Phencyclidine; Pregnancy; Psychomotor Performance; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Social Behavior | 2008 |
A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Hallucinogens; Humans; Macaca; Phencyclidine; Psychotic Disorders | 1983 |
Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
Topics: Animals; Apomorphine; Brain Chemistry; Disease Models, Animal; Humans; Male; Methadone; Motor Activity; Naloxone; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1981 |
Behavioral effects of phencyclidine (PCP) in the dog: a possible animal model of PCP toxicity in humans.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dogs; Male; Phencyclidine; Seizures | 1981 |
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Caudate Nucleus; Disease Models, Animal; Dopamine; Hydroxyindoleacetic Acid; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Mice; Mutation; Norepinephrine; Phencyclidine; Putamen; Serotonin; Tryptophan Hydroxylase | 1994 |
Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
Topics: Animals; Biological Assay; Disease Models, Animal; Dizocilpine Maleate; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Peptide Fragments; Phencyclidine; Receptors, Opioid, mu; Spinal Cord; Substance P | 1994 |
Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].
Topics: Action Potentials; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Motor Activity; Neurons; Phencyclidine; Rats; Schizophrenia; Serotonin Antagonists; Time Factors | 1995 |
Effect of a single injection of psychoactive drugs on CCK mRNA in rat brain.
Topics: Animals; Brain Chemistry; Cholecystokinin; Disease Models, Animal; Male; Methamphetamine; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Wistar; RNA, Messenger | 1994 |
A rat model of phencyclidine psychosis.
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Memory; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Wistar | 1994 |
Dissimilar patterns of degeneration in brain following four different addictive stimulants.
Topics: Animals; Brain; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Methamphetamine; Nerve Degeneration; Phencyclidine; Rats; Substance-Related Disorders | 1993 |
Thienylphencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury.
Topics: Animals; Disease Models, Animal; Evoked Potentials, Somatosensory; Male; Motor Activity; Phencyclidine; Photochemistry; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 1993 |
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Chronic Disease; Depressive Disorder; Disease Models, Animal; Hallucinogens; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Phencyclidine; Schizophrenic Psychology; Swimming | 1995 |
[Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP].
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clozapine; Desipramine; Disease Models, Animal; Humans; Immobilization; Mice; Phencyclidine; Risperidone; Schizophrenia; Swimming | 1996 |
Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine.
Topics: Adrenergic Agents; Animals; Cerebral Cortex; Cocaine; Disease Models, Animal; Electroencephalography; Hallucinogens; Hippocampus; Male; Methamphetamine; Phencyclidine; Rabbits; Schizophrenia | 1997 |
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chlorocebus aethiops; Clozapine; Cognition; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Humans; Phencyclidine; Prefrontal Cortex; Schizophrenia; Time Factors | 1997 |
Schizophrenia clues from monkeys.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chlorocebus aethiops; Clozapine; Cognition; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Memory; Phencyclidine; Prefrontal Cortex; Schizophrenia; Schizophrenic Psychology | 1997 |
A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dextroamphetamine; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hallucinogens; Haloperidol; Male; Motor Activity; Phencyclidine; Predictive Value of Tests; Rats; Rats, Wistar; Schizophrenia; Social Behavior; Stereotyped Behavior | 1998 |
Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Drug Administration Schedule; Haloperidol; Limbic System; Male; Motor Activity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Stress, Psychological; Time Factors | 1998 |
Haloperidol potentiates the EEG slowing of MK-801 despite blocking its motor effects: implications for the PCP model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Electroencephalography; Electromyography; Excitatory Amino Acid Antagonists; Hallucinogens; Haloperidol; Male; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Sleep, REM | 1998 |
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.
Topics: Animals; Bridged Bicyclo Compounds; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agonists; Glutamic Acid; Male; Memory; Motor Activity; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schizophrenia; Stereotyped Behavior; Synaptic Transmission | 1998 |
The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone.
Topics: Amidines; Animals; Antipsychotic Agents; Disease Models, Animal; Enzyme Inhibitors; Hallucinogens; Inhibitory Concentration 50; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phencyclidine; Rats; Rats, Sprague-Dawley; Reflex, Startle | 1999 |
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.
Topics: Animals; Antipsychotic Agents; Antisocial Personality Disorder; Behavior, Animal; Calcium Signaling; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Haloperidol; Male; Mice; Mice, Knockout; Motor Activity; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Schizophrenic Psychology; Serotonin Antagonists; Sexual Behavior, Animal; Social Behavior; Stereotyped Behavior | 1999 |
Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Disease Models, Animal; Drug Implants; Habituation, Psychophysiologic; Hallucinogens; Injections, Intraperitoneal; Male; Neural Inhibition; Phencyclidine; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Reflex, Startle | 1999 |
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Antimetabolites; Antipsychotic Agents; Binding Sites; Cycloleucine; Cycloserine; Disease Models, Animal; Dopamine Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine; Hallucinogens; Locomotion; Male; Phencyclidine; Phthalazines; Protein Structure, Tertiary; Psychotic Disorders; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Reflex, Startle | 1999 |
Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine.
Topics: Animals; Arousal; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Electroencephalography; Evoked Potentials; Hallucinogens; Hippocampus; Male; Methamphetamine; Motor Activity; Phencyclidine; Psychomotor Performance; Rats; Rats, Long-Evans; Schizophrenia; Septum of Brain | 2000 |
N-Methyl-D-aspartic acid- and metaphit-induced audiogenic seizures in rat model of seizures.
Topics: Animals; Disease Models, Animal; Electroencephalography; Male; N-Methylaspartate; Phencyclidine; Rats; Rats, Wistar; Seizures | 2000 |
[Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Disease Models, Animal; Glutamates; Immobilization; Mice; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists | 2000 |
Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.
Topics: Animals; Discrimination Learning; Disease Models, Animal; Dizocilpine Maleate; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Hallucinogens; Ketamine; Male; N-Methylaspartate; Phencyclidine; Rats; Rats, Inbred F344; Schizophrenia | 2000 |
Atypical antipsychotic effects of quetiapine fumarate in animal models.
Topics: Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Disease Models, Animal; Female; Haloperidol; Immobilization; Male; Mice; Phencyclidine; Rats; Rats, Wistar; Schizophrenia; Schizophrenia, Paranoid | 2000 |
Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43.
Topics: Amphetamine; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine Agents; Dopamine Antagonists; Drug Administration Schedule; Excitatory Amino Acid Antagonists; GAP-43 Protein; Haloperidol; Male; Neostriatum; Neurons; Phencyclidine; Psychoses, Substance-Induced; Psychotic Disorders; Rats; Rats, Inbred Strains; RNA, Messenger | 2001 |
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
Topics: Animals; Brain; Chromogranin A; Chromogranin B; Chromogranins; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Immunohistochemistry; Male; Neuronal Plasticity; Neurons; Neuropeptides; Peptide Fragments; Phencyclidine; Proteins; Psychoses, Substance-Induced; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia; Secretogranin II; Secretory Vesicles; Synaptic Transmission | 2001 |
Elucidating the role of muscarinic receptors in psychosis.
Topics: Alzheimer Disease; Animals; Cell Fractionation; Cell Line; Cell Membrane; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists; GTP-Binding Protein alpha Subunits, Gq-G11; Guanosine 5'-O-(3-Thiotriphosphate); Heterotrimeric GTP-Binding Proteins; Hippocampus; Humans; Male; Memory; Mice; Mice, Knockout; Motor Activity; Muscarinic Agonists; Neurons; Oxotremorine; Phencyclidine; Radioligand Assay; Receptors, Muscarinic; Schizophrenia; Signal Transduction | 2001 |
Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats.
Topics: Adenosine; Animals; Antipsychotic Agents; Brain; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Genes, Immediate-Early; Gyrus Cinguli; Hallucinogens; Head Movements; Male; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Psychotic Disorders; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger | 2002 |
Control of drug self-administration: the role of aversive consequences.
Topics: Alcoholic Intoxication; Aversive Therapy; Behavior; Chronic Disease; Disease Models, Animal; Electroshock; Heroin Dependence; Humans; Phencyclidine; Self Administration; Self Stimulation; Substance-Related Disorders | 1978 |
Progress report from the NIDA Addiction Research Center.
Topics: Animals; Decerebrate State; Disease Models, Animal; Dogs; Humans; Ketamine; Mice; Phencyclidine; Receptors, Opioid; Research Design; Self Administration; Substance-Related Disorders; United States; United States Public Health Service | 1979 |
Brain function in epilepsy: midbrain, medullary, and cerebellar interaction with the rostral forebrain.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Cobalt; Disease Models, Animal; Electric Stimulation; Electroencephalography; Epilepsy; Evoked Potentials; Haplorhini; Limbic System; Lysergic Acid Diethylamide; Medulla Oblongata; Mesencephalon; Olivary Nucleus; Pentylenetetrazole; Phencyclidine; Seizures | 1976 |
Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Conditioning, Operant; Conditioning, Psychological; Disease Models, Animal; Male; Phencyclidine; Rats; Rats, Inbred Strains; Schizophrenic Psychology | 1992 |
Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia.
Topics: Animals; Body Temperature; Brain; Brain Ischemia; Disease Models, Animal; Hypothalamus, Posterior; Ischemic Attack, Transient; Male; Mice; N-Methylaspartate; Phencyclidine; Pyridines; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1991 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; Glutamates; Glutamic Acid; Male; Microinjections; Parkinson Disease; Phencyclidine; Rats; Receptors, Glutamate; Receptors, Neurotransmitter; Sulpiride | 1990 |
N-methyl-D-aspartate receptors mediate activation of the c-fos proto-oncogene in a model of brain injury.
Topics: Animals; Anticonvulsants; Atropine; Brain; Brain Injuries; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; DNA-Binding Proteins; Female; Gene Expression Regulation; Immunohistochemistry; Ketamine; Male; Nifedipine; Phencyclidine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Male; N-Methylaspartate; Phencyclidine; Phenytoin; Rats; Rats, Inbred F344 | 1990 |
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.
Topics: Animals; Anticonvulsants; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ketamine; Male; Phencyclidine; Rats; Rats, Inbred Strains; Reflex, Startle; Schizophrenic Psychology; Touch | 1989 |
Inciting excitotoxic cytocide among central neurons.
Topics: Action Potentials; Animals; Brain; Cell Survival; Chick Embryo; Cholinergic Fibers; Disease Models, Animal; Edema; Epilepsies, Partial; Folic Acid; Hippocampus; Hypoxia; Kainic Acid; Ketamine; Microscopy, Electron; Parasympathomimetics; Phencyclidine; Piperidines; Seizures; Synaptic Transmission; Thalamus | 1986 |
Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Caudate Nucleus; Chromaffin System; Disease Models, Animal; Dopamine; Humans; Nerve Regeneration; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Phencyclidine; Pyridines; Receptors, Dopamine; Substantia Nigra; Synaptic Transmission | 1987 |
Animal models of intravenous phencyclinoid self-administration.
Topics: Animals; Cocaine; Conditioning, Operant; Disease Models, Animal; Female; Infusions, Intravenous; Ketamine; Phencyclidine; Phencyclidine Abuse; Rats; Reinforcement Schedule; Self Administration; Substance-Related Disorders | 1987 |